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General introduction 
 
 
 
 
1.1  Breast cancer 
Breast cancer is developed from breast tissue, whose symptoms including a lump appeared in the breast 
site, a change of breast shape, fluid released from a nipple, a red or scaly patch of skin [1]. Nowadays, breast 
cancer has become one of the major threats to human health with over one million people diagnosed every 
year [2, 3]. One-third of new cancer patients attribute to breast cancer, and breast cancer has become one of 
the major leading causes of death especially for women aged 40-50 [4].  
Despite many technical breakthroughs have been made in cancer therapy, complete healing is difficult 
using traditional therapeutic approaches including surgical resection, chemo- or radio-therapy [5, 6]. An ideal 
cancer therapeutic strategy should not only eradicate the primary tumor but also induce systemic anti-tumor 
immunity through activating the immune system to control metastatic tumor and prevent tumor recurrence [7, 
8]. Moreover, a large breast defect is mostly accompanied after breast tumor resection, which is difficult to 
self-heal [9]. Therefore, new functional tissues should be reconstructed or regenerated to fill the large 
surgical defects [1, 10]. 
1.1.1  Traditional therapies and their limitations for cancer treatment  
Over the past decades, several traditional cancer therapies including surgery, chemotherapy, and 
radiotherapy have been developed and widely applied in clinic [11-13]. Among them, surgical resection is 
most widely used and preferred therapy because this method can directly and effectively remove the primary 
tumor and has no biological resistance [14]. However, as shown in Fig. 1.1, surgical resection is difficult to 
eliminate all the tumor cells due to their blurry boundary between tumor and healthy tissue, which might 
cause cancer metastases and recurrence. Moreover, surgical resection is mostly accompanied by 
tumor-initiated breast defects, which are difficult to self-heal [9].    
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Fig. 1.1 Limitations of surgical resection for breast cancer  
 
Since the middle of 20th century, chemotherapy has been discovered and developed for cancer therapy 
[15]. Chemotherapy is a type of cancer treatment that uses certain drugs to kill tumor cells or to prevent them 
from growing and migrating to other parts of the body. Until now, various types of anti-tumor drugs have 
been explored for chemotherapy [16-18]. For breast cancer therapy, many chemotherapeutic drugs such as 
abraxane, adriamycin, carboplatin, xeloda, doxil, and halaven have been widely used in the clinic [19-21]. 
However, all the chemortherapeutic drugs have no specificity to tumor cells, which will induce severe side 
effects such as hair loss, immunosuppression, and normal tissue damage [22]. Moreover, the tumor cells will 
become resistant to chemortherapeutic drugs after long-term chemotherapy, further results in the failure of 
cancer therapy [23]. 
Radiotherapy uses high-energy particles or waves such as x-ray, γ-ray, electron beams or protons to 
destroy tumor cells [24]. Unlike chemotherapy, radiotherapy is usually a local treatment. This method is 
focused on the tumor site to damage tumor cells with little harm to nearby healthy cells [25]. However some 
side effects can still occur such as skin atrophy and hair loss. 
In summary, although these traditional therapies have been widely used in the clinic, a reliable cure is 
still limited. Therefore, novel approaches with specificity and high efficiency to tumor cells are urgently 
desired.  
1.1.2  New strategies for breast tumor therapy 
Due to the limitations of conventional cancer therapy, new therapeutic strategies such as gene therapy, 
immunotherapy, and hyperthermia therapy has been explored in recent years, which are introduced in detail 
as follows.  
I. Gene therapy 
Gene therapy refers to the ability of altered genes or site-specific modification, which is a valid and 
promising tool to treat different kinds of diseases such as heart disease, diabetes and cancer. Gene therapy 
works by delivering a healthy copy of a defective gene into patients’ cells [26-28]. In order to improve the 
therapeutic efficiency of delivered genes, vectors have been developed to deliver the gene as shown in Fig. 
1.2. The vector is divided into virus and non-viral such as plasmid, nanoparticle, liposome, cationic polymer 
[29]. Compared with non-viral vectors, the virus has become the most commonly used vectors because of its 
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high efficiency in invading cells and introducing related genetic materials. Nevertheless, virus vectors always 
cause strong immune problems [30, 31]. While non-viral vectors will not trigger big immune problem, but it 
shows low gene transfection efficacy and weak specific target ability, which cannot meet the requirement of 
gene delivery in the clinic [32, 33]. 
Fig. 1.2 The principle of gene therapy 
 
II. Immunotherapy 
Immunotherapy is the use of natural immune system’s activation for inhibiting primary and metastatic 
tumor growth [34]. Since the immunotherapy is firstly discovered by Steven Rosenberg in the late 1980s, 
immunotherapy has been widely developed and used in the clinic. Based on the immune mechanisms, 
immunotherapy is divided into several types as shown in Fig. 1.3, which includes monoclonal antibody 
immunotherapy, checkpoint inhibitor immunotherapy, engineered T cell-mediated immunotherapy and so on 
[35]. A monoclonal antibody refers to a specific protein and this kind of protein stays in the whole body and 
then bind to a tumor-associated antigen, further activate the immune system [36]. During immune responses, 
immune inhibition is always caused by the secretion of CTLA-4, PD-1, and PD-L1, which will inhibit the 
activation of T cells [37, 38]. In order to increase the number of activated T cells, T cells can be designed to 
express chimeric antigen receptors (CAR) by genetic engineering and then the engineered CAR-T cells can 
be injected into patients to activate the immune system and kill tumor cells [39].     
Fig. 1.3 The principle of immunotherapy 
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III. Hyperthermia therapy 
Hyperthermia therapy, known as thermal ablation of the tumor, is based on that high temperature (> 43 
oC) causes tumor cells apoptosis or necrosis by damaging proteins and structure of tumor cells [40]. The 
successful thermal ablation is preferred that the whole tumor tissue is destroyed while the adjacent normal 
cells or tissues structure are minimally injured [41]. In order to precisely control the temperature in tumor 
site, several novel methods including radiofrequency waves, ultrasound, alternative magnetic therapy, and 
photothermal therapy have been widely explored as shown in Fig. 1.4 [42-45]. The key requirement for 
thermal technology is that it should be minimally invasive. Appropriate heat depresses the metabolic rate of 
targeted cells, increases blood flow and also decreases oxygen demand in the tumor. The enhanced 
permeability of vessel might improve the accumulation of delivered agents in tumor site [46]. Integration of 
hyperthermia with emerging technologies, such as near infrared (NIR) absorption of nanoparticles, displays 
more potential of hyperthermia for cancer therapy [47, 48]. 
Fig. 1.4 The principle of hyperthermia therapy 
1.1.3  Functional biomaterials for breast reconstruction 
As above mentioned, all the large breast defects are accompanied by breast tumor resection, which is 
difficult to self-heal [9]. Therefore, adipose tissue regeneration induced by functional biomaterials is strongly 
desired to achieve breast reconstruction (Fig. 1.5) [49-51]. 
 
Fig. 1.5 Overview of breast reconstruction: the application of injectable hydrogel and porous scaffold   
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An ideal strategy for breast reconstruction is the combination of adipose- or bone marrow-derived stem 
cells with functional biomaterials [52-54]. Moreover, the functional biomaterials should bear soft tissue-like 
mechanical properties and mimic ECM compounds to regulate the adipogenic differentiation of stem cells 
[55-59]. Up to date, injectable hydrogels and 3D porous scaffolds have been developed for adipose tissue 
engineering [60-62]. Injectable hydrogels have been widely used as a matrix platform to encapsulate cells in 
3D culture, whose properties effectively mimic ECM microenvironments [63]. More importantly, high water 
contents in hydrogel provide excellent biocompatibility and soft and rubbery properties of hydrogel closely 
resemble living tissue [64-66]. 3D porous scaffolds with well-controlled pore structures have also 
extensively used in adipose tissue regeneration [67]. Cell-cell interactivity in porous scaffolds is critical to 
stimulate adipose tissue regeneration [68]. The shape of scaffolds is easily remodeled to match with 
reconstructed tissue [68, 69]. Moreover, the compositions of scaffolds are facilely mediated to promote 
adipose tissue regeneration [10, 70, 71].      
1.2  Photothermal therapy  
In recent years, photothermal therapy as a minimally invasive and highly efficient antitumor strategy, 
has attracted great attention [72]. As shown in Fig. 1.6, photothermal conversion agents produce heat under 
near infrared laser irradiation, further raise the temperature of tumor and ablate tumor cells [73-75]. In this 
method, near infrared (NIR) light is preferable because it has high penetration depth (>20 mm) in biological 
tissue reaching muscle and bone (Fig. 1.6 a) and it also has minimal damage to normal tissue. [76, 77]. In 
addition, the photothermal agents should have high photothermal conversion efficiency in near infrared 
region and excellent photothermal ablation efficacy to tumor cells (Fig. 1.6 b). Therefore, the choice and 
accumulation of photothermal agents in tumor site  are critical to effectively ablate the tumor cells.[78, 79].  
 
Fig. 1.6 Illustration of photothermal therapy  
1.2.1  Nanosystems used for photothermal conversion agents 
The ideal photothermal conversion agents should be required to be water soluble, non-cytotoxicity, 
good photostability, high photothermal conversion efficiency and tumor-enrichment ability [80]. Nowadays, 
nano-scaled materials (20~300 nm) including organic and inorganic nanomaterial have received much 
attention due to their enhanced permeability and retention (EPR) effect and tunable surface plasmon 
resonance (SPR) property [81-83].  
As for organic nano-agent, it was divided into several typical classes including NIR dye micelles such 
as indocyanine green (ICG), porphysomes obtained by self-assembly of porphyrin lipids, protein-based 
agents such as BSA bound-squaraine (SQ) and HSA bound-IR82, and conjugated polymers such as 
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polyaniline nanoparticles (PANPs) [84-88] as shown in Fig. 1.7. These organic agents not only have high 
photothermal conversion efficiency but also have good biocompatibility and appropriate biodegradability [89, 
90]. However, there are still some challenges in the future clinical translation such as the poor photothermal 
stability of ICG and the safety of their degradation product [91]. 
 
Fig. 1.7 Organic photothermal nano-agents  
 
Compared with organic nano-agents, inorganic nano-agents have received much more attention in 
recent years. Various inorganic nanoparticles have been widely explored as shown in Fig. 1.8, which 
including noble metals such as gold nanoparticles, transition metal sulfide or oxide nanoparticles such as 
CuS and Fe3O4, carbon-based nanoparticles such as graphene [92-94]. Among them, gold nanoparticles with 
a different shape (sphere, rod, and star) and size were widely explored due to their tunable surface plasmon 
resonance property and facile preparation [95-97]. Despite many these inorganic nano-agents have shown 
high photothermal therapeutic efficiency in many researches, their non-biodegradability and potential 
long-term toxicity will restrict their future clinical translation [98]. 
 
Fig. 1.8  Inorganic photothermal nano-agents 
1.2.2  Problems of nanoparticles-mediated photothermal therapy   
Although photothermal therapy has been widely developed in recent years due to their high therapeutic 
efficiency to tumor cells, there are still several problems as follows: 
(1) Nanoparticle-mediated photothermal ablation therapy is mainly used in local cancer therapy in currently 
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used forms. While how the immune responses can be triggered by photothermally ablated tumor cells is still 
not clear [99, 100].  
(2) Although various nanoparticles have shown excellent photothermal conversion efficiency, efficacious and 
site-specific delivery of free nanoparticles to tumor site is still limited. Upon intravenous injection, most of 
free nanoparticles undergo uptake by macrophages of the mononuclear phagocyte system and some 
nanoparticles will distribute to healthy tissue such as liver and spleen, further the accumulation amount of 
nanoparticles in tumor site is very limited and results in low repeated heating efficiency [45, 101, 102]. 
1.2.3  Resolution to current problems   
In order to address these problems, the reasonable resolution is put forward as follows: 
(1). In order to overcome problem 1, the immune responses triggered by photothermal ablated tumor cells 
should be explored. It has been reported that dead tumor cells and their debris can trigger potent immune 
responses. Necrotic tumor cells can expose intracellular antigens and release damage associated proteins 
including calreticulin (CRT), ATP and heat shock protein (HSP) from cytosol and nucleus, which can 
stimulate systemic immune responses [8, 103, 104]. Apoptotic tumor cells associated with “danger signals” 
such as heat stress can up-regulate expression of membrane heat shock proteins HSPs (HSP72 and HSP60) 
and further elicit tumor-specific immunity [105-108]. Then the tumor-related antigens will be uptake by DCs 
and the released proteins will stimulate the DCs activation, then the mature DCs activate the T cells, 
subsequently activated T cells will migrate into tumor site and elicit tumor-specific immunity as shown in 
Fig. 1.9 [37, 109-111]. Therefore, it is desired to investigate if the photothermally ablated tumor cells could 
induce similar immune responses.  
 
 
Fig. 1.9 Immune responses triggered by ablated tumor cells 
 
(2). In order to overcome problem 2, some carriers have been explored to load and deliver NPs to the tumor 
site. Up to now, there are two kinds of carriers: cell-based carriers and scaffold-based carriers. As for the 
cell-based carriers, the macrophage and stem cells were used to load NPs and migrate to tumor site [112-114]. 
However this method may cause second malignancy by the implanted cells transformation. As for the 
scaffold-based carriers, the NPs was immobilized into the scaffold to prepare photothermal scaffold [70]. 
This method could realize high repeated heating efficiency. And this kind of scaffold could not only ablate 
tumor cells using their photothermal conversion property but also support normal cells penetration and repair 
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the tumor-initiated tissue defects after tumor ablation, which has been used for bone and skin cancer therapy 
[115-117]. So, I will focus on the preparation of photothermal scaffold in my study.   
 
1.3  Bifunctional scaffolds for photothermal therapy and tissue regeneration 
As introduced in 1.1.3, large tissue defects are always accompanied with tumor therapy, which is 
difficult to self-heal. Therefore, it has been developed bifunctional scaffolds for both ablations of tumor and 
regeneration of new tissue in recent years. Wu. et al. reported that 3D-printed scaffolds of graphene 
oxide-modified tricalcium phosphate bioceramic showed both excellent photothermal therapy for bone tumor 
and the regeneration of bone tissue [115]. It has also been reported that electrospun micropatterned PLA/PCL 
incorporated Cu2S fiber membranes exhibited skin tumor therapy and wound healing [118]. As a result, 
bifunctional scaffolds incorporated with photothermal agents has received much attention for photothermal 
cancer therapy and tissue regeneration. 
1.3.1  Immobilization of photothermal agents into scaffolds 
Various photothermal agents such as graphene, Cu2S, polydopamine are immobilized into porous 
scaffolds using different methods. For example, MoS2-modified akermanite (AKT) scaffolds were prepared 
by in situ growing MoS2 nanosheets on 3D-printed AKT bioceramic scaffolds using hydrothermal reaction 
[117]. While PLA/PCL incorporated Cu2S fiber membranes were fabricated by directly mixing PLA/PCL 
solution with Cu2S suspension before electrospinning [118]. Therefore, immobilization of photothermal 
nano-agents into porous scaffolds through various methods will be widely explored in the preparation of 
bifunctional scaffolds.    
1.3.2  Requirement of scaffolds for adipose tissue regeneration 
In order to achieve breast reconstruction, the scaffolds should support attachment, penetration, and 
proliferation and adipogenic differentiation of stem cells [119]. Therefore, scaffolds should meet the 
following requirements. 
I. Biocompatibility 
Scaffolds is required to be biocompatible with the cells and adjacent biological tissue [120]. Moreover, 
scaffolds should be beneficial to the attachment, proliferation and regulating adipogenic differentiation of 
stem cells [121]. In addition, degradation products of scaffolds should be non-cytoxic and non-inflammatory 
to cells and surrounding tissues. 
II. Proper degradability 
Scaffolds should be degradable after implantation and their degradation rate should be matched with the 
growth rate of new tissues, further the implanted scaffolds should be replaced by the newly formed 
engineered tissues at last [122, 123]. 
III. Suitable mechanical property 
Scaffolds should bear a certain mechanical strength, which not only support cell growth but also match 
with the mechanical property of implant-position [124]. As shown in Fig. 1.10, there are various mechanical 
strength with different organs. The elastic modulus of adipose tissue (0.5~1 kPa) is much lower than that of 
bone tissue (15000 ~20000 kPa), which indicated the scaffolds used for adipose tissue regeneration should 
bear soft tissue-like mechanical property [125]. Therefore, gelatin scaffolds have been reported to be 
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favorable for adipose tissue regeneration due to their low elastic modulus, as compared to stiff scaffolds such 
as poly(lactic-co-glycolic acid) scaffolds [56, 57, 126]. 
 
Fig. 1.10 Elastic modulus of different tissue. 
 
IV. Porous structure 
3D scaffolds should have an appropriate pore structure with open and interconnected pores to promote 
cell penetration, distribution and support nutrition and metabolite exchange [127]. Moreover, cell-cell 
interactivity in porous scaffolds plays critical roles in regulating adipose tissue regeneration [128]. Therefore, 
the controlled pore structure including proper pore size, well interconnectivity and porosity is urgently 
required for adipose tissue regeneration. 
1.3.3  Fabrication methods of porous structure 
As is well known, the suitable pore structure of the scaffolds is good for cell penetration, cell-cell 
interaction and new tissue formation. Therefore, it has been developed several commonly used methods 
including electrospinning method, 3D printing method and porogen-based methods for preparing porous 
scaffold until now [129-131].  
I. Electrospinning method 
Electrospinning, as a common used electrostatic fiber fabrication technique, has received much attention 
in recent years [132]. The device used for electrospinning consists of a syringe pump containing polymer 
solution, a metal collector and a high voltage supplier [133]. Among them, types of polymers and setting of 
parameters are the key factors which determine the quality and application of electrospun scaffolds. Various 
polymers such as collagen as typical natural polymer and PLGA polymers as synthetic polymers could be 
used this method to prepare porous fibers scaffolds for tissue engineering [134, 135]. However, there are 
some disadvantages such as too small pore size and too small thickness to limit their application [136]. In 
addition, the organic solvent used in this method has certain toxicity to cells and tissues [137]. 
II. 3D printing method 
3D  printing technology has been extensively developed to construct different pore structure of 
scaffolds in recent years [138]. Many biomaterials including inorganic bioceramic such as hydroxyapatite 
(HA) and organic polymers such as chitosan and PCL has been used in printing inks to prepare porous 
scaffolds [139-141]. This method could easily control the pore size, pore shape, and porosity of scaffolds. 
Moreover, the thickness and shape of the scaffolds could be easily constructed using this method. What’s 
more, the printed pores have well interconnectivity, which is benefit of cell penetration and distribution [142]. 
However, the expensive equipment is required for 3D printing, which will be limited to the application of 
this technique. 
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III. Porogen-based methods 
Several common used porogen such as sodium chloride particles, carbon dioxide (CO2) gas and ice 
crystals has been developed to construct the porous structure of scaffold recently [143]. The porous scaffolds 
are prepared by removal of porogen materials from the mixture. Based on different types of porogen, the 
porogen-based method was divided into particle leaching, gas foaming, and freeze-drying. 
Particle leaching method is using calibrated particles as a porogen to obtain pore structure of scaffolds. 
The calibrated particles consist of NaCl inorganic particle or paraffin organic microspheres, which are facile 
fabrication and easily removed during preparation process of scaffolds [144]. This method could regulate 
pore structure of scaffolds by changing the amount, shape and size of the calibrated particles. Nevertheless, 
there are still some limitations including limited thickness and poor interconnectivity of obtained scaffold. In 
order to completely remove all the immobilized particles from scaffolds, the thickness of prepared scaffold is 
usually controlled less than 2 mm. In addition, the immobilized particles is independent and not connected 
with each other in scaffolds, which results in the poor interconnectivity of scaffold. Moreover, the residue of 
immobilized particles might result in the toxicity for the cells and tissues. 
Gas foaming method is depended on the CO2 gas with high pressure in polymer disk and quickly 
releases of CO2 gas by decreasing pressure to ambient atmospheric pressure within 15 seconds, further form 
bubbles leading to the formation of highly porous scaffolds [145, 146]. The porosity of porous scaffolds 
prepared by this method reach to 93%. Nevertheless, there are still some limitations of this method such as 
closed pore structure and poor interconnectivity. 
Freeze-drying is using newly formed ice crystals during freezing process as porogen to obtain the pore 
structures through sublimation of ice crystals during the freeze-drying process [147]. The freezing rate and 
temperature could control the pore size and interconnectivity of scaffolds. Although the pore size could be 
controlled during freezing process, the pores are too small for cell penetration and distribution into porous 
scaffolds. Moreover, the pore structure is randomly formed in the polymer matrix, which has no certain 
shape. 
In order to solve their limitations, ice particles with proper size as an ideal template to prepare porous 
scaffolds (Fig. 11) have been explored in recent years [148]. This method is the combination of the particle 
leaching and freeze-drying methods. In this method, ice particles with proper size are optimized by sieving 
with different meshes and then mixed with polymer matrix to obtain porous scaffolds through freezing and 
freeze-drying. In addition, the size of spherical micropores could be well regulated by changing the size of 
pre-prepared ice particles and the interconnected pores could be formed by the new ice crystals around the 
ice particulates during freezing process [149]. Moreover, the porosity can be regulated by changing the 
amount of ice particulates. Therefore, the porous scaffolds with controlled pore size and well 
interconnectivity could be fabricated by using this method in this study. 
Fig. 1.11 Ice particles as an template to prepare polymer scaffold with controlled pore structure 
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1.4  Motivation, objective and outline 
1.4.1  Motivation and objective  
Despite many technical breakthroughs have been made in cancer therapy, complete healing is difficult 
using traditional therapeutic approaches including surgical resection, chemo- or radio-therapy. An ideal 
cancer therapeutic strategy should not only eradicate the primary tumor but also induce systemic anti-tumor 
immunity through activating the immune system to control metastatic tumor and prevent tumor recurrence. 
Meanwhile, new functional tissues should be reconstructed or regenerated to fill the tumor-initiated breast 
defects. Therefore, it is strongly desired to design a bifunctional material for effective breast cancer therapy 
and breast reconstruction. 
Photothermal therapy (PPT) as a minimally invasive and highly efficient antitumor strategy has 
attracted great attention in recent years. However, nanoparticle-mediated photothermal ablation therapy, in 
currently used forms, has been primarily used in local cancer therapy. It remains unclear how the immune 
responses can be triggered by photothermal ablated tumor cells, which may be useful for synergistic 
photothermal-immunotherapy of primary and metastatic cancer. In addition, although various nanoparticles 
(NPs) have excellent photothermal conversion efficiency, efficacious and site-specific delivery of free NPs to 
tumor site is still limited. To address these issues, the immobilization of NPs into three-dimensional (3D) 
scaffolds is necessary. In addition, gelatin-based materials have been used to prepare scaffolds for adipose 
tissue engineering because of their good biocompatibility and soft tissue-like mechanical property. Moreover, 
It have been reported that gold nanoparticles might affect the fate of stem cells such as cell phenotype, 
proliferation and differentiation.  
Based on the above background and motivation, the objective of this study is to prepare bifunctional 
scaffolds that can both ablate tumor cells and promote adipose tissue regeneration. To achieve this objective, 
this study was divided into three sub-targets as follows: 
(1) To evaluate the photothermal ablation effects of BSA-coated AuNRs towards breast tumor cells and 
investigate the immune responses triggered by photothermally ablated tumor. 
(2) To prepare AuNRs-gelatin porous composite scaffolds for photothermal ablation therapy of breast tumor cells 
and activation of dendritic cells. 
(3) To investigate the adipogenic differentiation of hMSCs in the AuNRs-gelatin porous composite scaffolds. 
1.4.2  Outline  
BSA-coated AuNRs were synthesized and bifunctional scaffolds of AuNRs and gelatin were prepared 
for breast cancer therapy and adipose tissue regeneration.  
In chapter 2, BSA-coated AuNRs were applied to evaluate their photothermal ablation effects after 
uptake by breast tumor cells. The immune-stimulatory responses of immature DCs triggered by the 
photothermally ablated tumor cells were investigated by direct co-culture or transwell co-culture of immature 
DCs and photothermally ablated tumor cells to disclose the involvement of cell–cell interaction and soluble 
factors in the immune responses of DCs 
In chapter 3, AuNRs-gelatin composite scaffolds were used to evaluate their photothermal performance 
by changing the incorporated Au concentration (0.0, 2.0, 4.0 mM) and varying power intensities of an 805 
nm laser. Their photothermal ablation efficiency of breast tumor cells was evaluated by in vitro cell culture 
and in vivo animal experiment. Moreover, the immune response of dendritic cells by photothermally ablated 
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tumor cells in AuNRs-gelatin composite scaffolds was also investigated.  
In chapter 4, The influence of AuNRs-gelatin composite porous scaffolds on adhesion, proliferation and 
adipogenic differentiation including lipid vacuoles formation and adipogenesis-related gene expression of 
human mesenchymal stem cells (hMSCs) was investigated by culture of hMSCs in the AuNRs-gelatin 
composite porous scaffolds for 14 days. 
In chapter 5, The summary and conclusion supported by this study were described and the future 
prospect of this study were also proposed.  
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2.1 Summary 
Nanoparticle-mediated photothermal therapy has been widely studied for cancer treatment. It is 
important to disclose how photothermally ablated tumor cells trigger immune responses. In this study, 
bovine serum albumin (BSA)-coated gold nanorods (BSA-coated AuNRs) were prepared and used for 
photothermal ablation of breast tumor cells. The BSA-coated AuNRs showed high photothermal conversion 
efficiency and good photothermal ablation effect towards tumor cells. The ablated tumor cells were 
co-cultured with immature dendritic cells (DCs) through a direct cell contacting model and diffusion model 
to confirm the stimulatory effects of cell–cell interaction and soluble factors released from ablated tumor 
cells. The results indicated that photothermally ablated tumor cells induced immune-stimulatory responses of 
DCs through both cell–cell interaction and soluble factors. The results should be useful for synergistic 
photothermal-immunotherapy of primary and metastatic cancer. 
2.2 Introduction 
Cancer is a severe threat to human life and causes more than seven million deaths each year [1]. Despite 
some technical breakthroughs that have been explored in cancer therapy, complete healing is difficult using 
traditional therapeutic approaches including surgical resection, chemo- or radio-therapy [2, 3]. In recent years, 
photothermal ablation therapy, which employs photothermal conversion agents produce heat under near 
infrared laser irradiation, further raise the temperature of tumor and ablate tumor cells, provides a highly 
efficient antitumor strategy for cancer therapy [4, 5]. Various nanomaterials such as polypyrrole, 
polydopamine, indocyanine green, carbon nanotubes, graphene oxide, molybdenum sulfide, tungsten oxide, 
CuS nanoparticles and gold-based nanoparticles can be used for photothermal ablation therapy [6-16]. Among 
them, gold nanoparticles with a different shape (sphere, rod, and star) and size were widely explored due to 
their tunable surface plasmon resonance property and facile preparation. However, nanoparticle-mediated 
photothermal ablation therapy, in currently used forms, has been primarily used in local cancer therapy 
[17-19]. 
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An ideal photothermal ablation therapy should not only eradicate the primary tumor but also induce 
systemic anti-tumor immunity through activating the immune system to control metastatic tumor and to 
prevent tumor recurrence [20, 21]. It has been reported that dead tumor cells and their debris can trigger potent 
immune responses [22-24]. Necrotic tumor cells can release intracellular antigens and damage associated 
proteins including calreticulin (CRT), ATP and heat shock protein (HSP) from cytosol and nucleus, which can 
stimulate systemic immune responses [22, 25, 26]. Apoptotic tumor cells associated with “danger signals” 
such as heat stress can up-regulate expression of membrane HSPs (HSP72 and HSP60) and further elicit 
tumor-specific immunity [27-29]. 
During immune responses, dendritic cells (DCs) have the most effective antigen-presentation for 
initiation of T cell-dependent immune responses as compared to other antigen-presenting cells such as 
macrophages or B cells [30-32]. Dendritic cell-based immunotherapy caused by necrotic tumor cells and 
apoptotic tumor cells with “danger signals” is a promising strategy to inhibit metastatic tumor recurrence [33, 
34]. However, it is not clear how the immune responses of DCs can be triggered by photothermally ablated 
tumor cells. 
In this study, BSA-coated AuNRs were prepared and used for photothermal ablation of breast tumor cells. 
The immune-stimulatory responses of immature DCs triggered by the photothermally ablated tumor cells were 
investigated by direct co-culture or transwell co-culture of immature DCs and photothermally ablated tumor 
cells to disclose the involvement of cell–cell interaction and soluble factors in the immune responses of DCs. 
2.3 Materials and methods 
2.3.1 Fabrication and characterization of BSA-coated AuNRs  
Gold nanorods were synthesized by a seed-mediated growth method [35-37]. Firstly, gold seed solution 
were obtained via the reaction of hydrogen tetrachloroaurate (Ⅲ) tetrahydrate (HAuCl4•4H2O, Wako) and 
sodium borohydride (NaBH4, Sigma) in hexadecyltrimethylammonium bromide (CTAB, 0.1 mol/L, 7.5 mL) 
aqueous solution. The Au seeds were used within 2 h after preparation. Subsequently, a growth solution was 
prepared by adding HAuCl4 (0.01 mol/L, 15.0 mL), HCl (1 mol/L, 6.0 mL), AgNO3 (0.01 mol/L, 3.3 mL) and 
ascorbic acid (0.1 mol/L, 2.4 mL) into CTAB (0.1 mol/L, 300.0 mL) aqueous solution. Finally, the 
pre-prepared gold seeds grew up along the silver crystal in the growth solution under gentle stirring for 12 h to 
allow the formation of AuNRs. The AuNRs were collected by centrifugation under 8000 rpm for 10 min. In 
order to remove the CTAB, the collected AuNRs were washed with ultrapure water. Moreover, bovine serum 
albumin (BSA) were coated on the surface of AuNRs by mixing AuNRs solution with 10 mg/mL BSA aqueous 
solution and the mixture solution was kept stirring for 1 day. Subsequently, the BSA-coated AuNRs were 
obtained by centrifugation under 8000 rpm for 10 min and suspended in ultrapure water for the following 
experiments. 
The morphology of AuNRs and BSA-coated AuNRs was characterized with a transmission electron 
microscope (TEM, JEM-2100F, JEOL Ltd., Tsukuba, Japan). The BSA coating layer on the surface of AuNRs 
was observed with copper grids containing super ultrahigh resolution carbon support film (Okenshoji Co., Ltd., 
Tokyo, Japan) by JEM-2100F TEM system at 200 kV accelerating voltage. The hydrodynamic size of 
BSA-coated AuNRs was measured using particle size analyzer (ELSZ-2000, Otsuka Electronics Co., Ltd., 
Osaka, Japan) under dynamic light scattering software. Moreover, the zeta potential of BSA-coated AuNRs 
was also measured using the same machine under zeta potential software [38]. The mean and standard 
deviation were calculated through three parallel samples. Fourier transform infrared (FTIR) spectrum was 
measured with an 8400S FTIR spectrometer (Shimadzu Corp., Kyoto, Japan). Visible-near infrared (VIS-NIR) 
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spectrum was measured using UV-VIS spectrophotometer (V-660, Jasco Corp., Tokyo, Japan). The 
concentration of Au was detected by inductively coupled plasma atomic emission spectrometry (ICP-AES, 
SPS3520UV-DD, SII Nano Technology Inc., Chiba, Japan). 
2.3.2 Photothermal performance of BSA-Coated AuNRs  
To evaluate photothermal performance of BSA-coated AuNRs, 80 μL aqueous suspension of 
BSA-coated AuNRs in medium with different gold concentration (0.0, 0.2, 0.4, 0.6, 0.8, 1.0 mM) in each 
well were used to irradiation under a near infrared (NIR) laser with the wavelength of 805 nm at different 
power intensities of 1.4, 1.6 and 1.8 W cm−2 for 10 min. Irradiation at the condition of power intensity of 1.6 
W cm−2 with irradiation time of 10 min was repeated five times to check the stability of the photothermal 
conversion of BSA-coated AuNRs. In addition, the real-time temperature was detected by inserting the 
thermocouple probe into BSA-coated AuNRs solution with different gold concentration and recorded with 
the digital thermometer (AS ONE Corp., Tokyo, Japan) during laser irradiation. 
2.3.3 Viability analysis of cells cultured with BSA-Coated AuNRs  
Viability of cells cultured with BSA-coated AuNRs was evaluated by WST-1 assay. Mouse breast 
tumor cells that stably express luciferase (4T1-Luc) were obtained from JCR cell bank (Tsukuba, Japan). The 
4T1-Luc cells were subcultured in RPMI1640 medium (Gibco, Grand Island, New York, USA) containing 
10% FBS in a humidified incubator at 37 °C. When the cells proliferated to 80% in the flask, the medium 
was removed and washed with PBS. Then 0.25% trypsin solution was added into flask and incubated for 5 
min to detach the cells from the surface of flask. The harvested 4T1-Luc cells were re-suspended in 
RPMI1640 medium and used for following experiments. 100 μL cell suspension solution with the 
concentration of 2.0 × 105 cells/mL was dropped into each well of a 96-well plate and cultured for 12 h to 
allow cell adhesion. Afterwards, the medium was changed to 100 μL fresh medium containing BSA-coated 
AuNRs at different Au concentrations (0.0, 0.2, 0.4, 0.6, 0.8 and 1.0 mM) and cultured for 24 h. 
Subsequently, the cell viability was evaluated by WST-1 assay. Briefly, after being removed the medium, 
100 μL 10% WST-1 dilute solution was added into each well and incubated for 3 h at 37 °C. Then, the 
absorbance of WST-1 solution was detected via a microplate reader at the wavelength of 440 nm. The mean 
and standard deviation were calculated through three parallel samples of each group. 
2.3.4 Cellular uptake assay of BSA-Coated AuNRs  
Uptake amount of AuNRs by breast tumor cells in vitro was measured via ICP-AES. At first, breast 
tumor cells (4T1-Luc cells, 2 × 105 cells/well) were seeded and cultured in culture plate for 12 h to make cell 
adhesion. Subsequently, the 0.0, 0.2, 0.4 and 0.6 mM BSA-coated AuNRs in medium were used to treat with 
4T1-Luc cells for 6 h. Then the free BSA-coated AuNRs were removed via washing with phosphate buffer 
solution. After that, the adhered cells were detached from each well and then the detached cells were 
centrifuged and re-suspended in phosphate buffer solution. The number of harvested cells was calculated 
using the hemocytometer. Finally, the nitrohydrochloric acid was used to lyse the collected cells. Then the 
gold amount in each group was detected with ICP-OES. The mean and standard deviation were calculated 
through three parallel samples of each group.   
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2.3.5 Photothermal ablation of breast tumor cells by BSA-Coated AuNRs  
The 4T1-Luc cells (2 × 104 cells/well) were seeded in culture plate and cultured for 12 h to make cell 
attachment. Subsequently, the 0.0, 0.2, 0.4 and 0.6 mM BSA-coated AuNRs in medium were used to treat 
with 4T1-Luc cells for 6 h. Then the free BSA-coated AuNRs were removed via washing with phosphate 
buffer solution. Each well containing 4T1-Luc cells after uptake of BSA-coated AuNRs were used to 
irradiation under a near infrared (NIR) laser with the wavelength of 805 nm at the power intensities of 1.6 W 
cm−2 for 10 min. After that, the breast tumor cells were cultured in RPMI1640 medium supplemented with 
10% FBS for another 4 h. The live and dead cells before and after laser irradiation were stained by 
Calcein-AM/PI double staining kit (Dojindo, Kumamoto, Japan). The stained cells in 96-well plate were 
observed by an inverted fluorescence microscope (Olympus, Tokyo, Japan). In addition, cell viability before 
and after laser irradiation was quantified by a WST-1 assay. The mean and standard deviation were 
calculated through three parallel samples of each group. 
2.3.6 Interaction between DCs and ablated breast tumor cells 
The 4T1-Luc cells (2 × 104 cells/well) were seeded into 96-well plates and cultured for 12 h. 
Subsequently, the 0.4 mM BSA-coated AuNRs in fresh medium were used to treat with 4T1-Luc cells for 6 
h. After that, the free BSA-coated AuNRs were removed via washing with phosphate buffer solution. Each 
well containing 4T1-Luc cells after uptake of BSA-coated AuNRs were used to irradiation under a near 
infrared (NIR) laser with the wavelength of 805 nm at the power intensities of 1.6 W cm−2 for 10 min. 
 Mouse bone marrow-derived immature DCs (ATCC, Manassas, Virginia, USA) were used to 
investigate immune responses induced by photothermally ablated tumor cells. Dendritic cells were cultured 
in MEM-α medium containing 20% fetal bovine serum and 5 ng/mL GM-CSF, whose growth property was a 
mixture of adherent and floating cells. For subculture of DCs, the adherent cells were detached by a 0.25% 
trypsin solution, and the floating cells were directly transferred into tubes. After the detached cells and 
floating cells were mixed in tubes, then all the cells were collected by centrifugation under 1000 rpm for 10 
minutes. The cells were re-suspended in fresh medium and used for subculture. Culture medium was 
changed once per week. 
To investigate interaction between DCs and photothermally ablated 4T1-Luc cells, three experiments 
were conducted. The first experiment was designed to investigate the effect of soluble factors released from 
the ablated 4T1-Luc cells. Dendritic cells (1 × 104 cells/well) were seeded in a 96-well transwell insert which 
consisting of the porous membrane (the diameter of pore: 1.0 μm ). The transwell insert was put in the upper 
of a 96-well receiver plate cultured the ablated 4T1-Luc cells, which enabled diffusion of soluble factors 
while blocking direct cell-to-cell contact (diffusion model). The second experiment was designed to 
investigate the effect of cell–cell interaction. The soluble factors released from the ablated 4T1-Luc cells 
were completely removed by washing with phosphate buffer solution in each well. After washing, DCs (1 × 
104 cells/well) suspension were dropped in the 96-well culture plate containing the ablated 4T1-Luc cells 
(cell contacting model). The third experiment was designed to investigate the effects of both soluble factors 
and cell–cell interaction. Dendritic cells (1 × 104 cells/well) suspension were directly dropped in the 96-well 
culture plate after photothermal ablation of 4T1-Luc cells (combination effects of diffusion model and cell 
contacting model). As positive and negative controls, DCs (1 × 104 cells/well) suspension were dropped in 
blank 96-well culture plate and incubated with or without 1 μg/mL lipopolysaccharide (LPS) stimulation, 
respectively. For all the experiments, DCs were incubated in MEM-α medium with 5 ng/mL GM-CSF for 24 
h. Finally, DCs supernatants were harvested to measure the secretion amount of cytokines including 
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interleukin 6, 12 and 1β (IL-6, 12 and 1β), tumor necrosis factor alpha (TNF-α) by the Elisa kit based on the 
protocol referred by company instruction (PEPROTECH, Rocky Hill, New Jersey, USA). The mean and 
standard deviation were calculated through three parallel samples of each group.  
2.3.7 Statistical analysis 
The quantitative experiment in this study was repeated using three parallel samples and the results were 
expressed with average ± standard deviation (SD). The statistical analysis including significant difference 
was carried out by one-way ANOVA analysis software. The p value of 0.05 was considered statistically 
significant difference. The data were classified according to their p values and denoted by (*) for p less than 
0.05, (**) for p less than 0.01 and (***) for p less than 0.001. 
2.4 Results 
2.4.1 Physical and chemical properties of BSA-Coated AuNRs  
The morphology of AuNRs and BSA-coated AuNRs was observed by TEM. Transmission electron 
microscopy images (Fig. 2.1a) showed that the gold nanoparticles had a rod-like structure. Gold nanorods 
and BSA-coated AuNRs had the same morphology and dimension. Their dimension measured from TEM 
images was 62.3 ± 4.5 nm × 11.6 ± 3.8 nm. The TEM image of BSA-coated AuNRs demonstrated the BSA 
coating layer on the surface of AuNRs. Moreover, the hydrodynamic size of AuNRs and BSA-coated AuNRs 
distributed in water was measured by dynamic light scattering (DLS) as shown in Fig. 2.1b. The average 
hydrodynamic size of AuNRs and BSA-coated AuNRs was 55.3 ± 5.8 and 68.1 ± 8.2 nm, respectively. The 
average hydrodynamic size of BSA-coated AuNRs was a little larger than that of AuNRs, which should be 
due to the swelling of BSA coating on the surface of AuNRs. Zeta potential of AuNRs and BSA-coated 
AuNRs (Fig. 2.1c) was detected to check the change of surface-charge after BSA coating. The results 
demonstrated that the zeta potential of AuNRs and BSA-coated AuNRs was 41.43 ± 3.80 and −28.82 ± 1.63 
mV, respectively, which indicated the surface charge of AuNRs was changed from positive to negative after 
BSA coating. 
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Fig. 2.1 High-resolution transmission electron microscopy image (a), distribution of hydrodynamic sizes (b) 
and zeta potentials (c) of gold nanorods (AuNRs) and BSA-coated AuNRs. 
Fourier transform infrared spectrum was used to further confirm the successful coating of BSA on the 
surface of AuNRs. As shown in Fig. 2.2a, the BSA-coated AuNRs showed two apparent peaks at the 
wavenumber of 1640 and 1524 cm−1, which is ascribed to the NH2-I and II band NH2-II of bovine serum 
albumin (BSA). While for the AuNRs without coating, no peaks were detected at the same wavenumber, 
which indicated the bovine serum albumin was successfully coated on the surface of AuNRs. Bovine serum 
albumin molecules should be bound to the surface of AuNRs through electrostatic interaction of positively 
charged AuNRs and negatively charged BSA and Au-S bond between AuNRs and thiol groups in BSA. 
Colloid solutions of BSA-coated AuNRs in ultrapure water and medium were stable without aggregation for 
a long time, indicating stable BSA coating on the surface of AuNRs. Protein-coating has been reported to 
increase colloid stability of gold nanorods [39]. 
A visible-near infrared absorption spectrum (Fig. 2b) was used to characterize the optical property of 
AuNRs. Both AuNRs and BSA-coated AuNRs demonstrated two apparent absorbance peaks at 535 nm and 
848 nm, which corresponded to their transverse and longitudinal plasmon modes, respectively. 
Fig. 2.2 Fourier transform infrared spectra of bovine serum albumin (BSA), AuNRs and BSA-coated AuNRs 
(a) and VIS-NIR spectra of AuNRs and BSA-coated AuNRs (b). 
2.4.2 Photothermal performance of BSA-Coated AuNRs  
Photothermal performance of BSA-coated AuNRs was evaluated by irradiation with an 805 nm laser. 
Different laser irradiation power densities (1.4, 1.6 and 1.8 W cm−2) were used. Heating curves (Fig. 2.3a–c) 
showed that the temperature of BSA-coated AuNRs aqueous solution in medium increased rapidly compared 
with control group (0.0 mM, only medium without AuNRs). Temperature increase rate became faster when 
Au concentration was higher and the laser intensity became stronger. Temperature change data (Fig. 2.3d) 
after laser irradiation with an intensity of 1.4, 1.6 and 1.8 W cm−2 for 10 min indicated that the temperature 
change of BSA-coated AuNRs aqueous solution increased from 5.9 ± 0.7 to 30.1 ± 4.8 °C, from 8.5 ± 1.1 to 
34.4 ± 3.8 °C and from 12.3 ± 1.6 °C to 44.5 ± 6.1 °C, respectively, when the concentration of AuNRs 
aqueous solution varied from 0.0 mM to 1.0 mM. All these results suggested that the BSA-coated AuNRs 
had an excellent photothermal conversion efficiency and their photothermal conversion efficiency could be 
modulated by changing AuNRs concentration in the aqueous solution and laser power intensity. Laser power 
density of 1.6 W cm−2 was used in following experiments because temperature increase of BSA-coated 
AuNRs solution was high while temperature change of control (medium without AuNRs) was not so high. 
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Fig. 2.3 Heating curves of BSA-coated AuNRs aqueous solution at different Au concentration of 0.0, 0.2, 0.4, 
0.6, 0.8 and 1.0 mM under continuous NIR irradiation with different laser power intensity of 1.4, 1.6 and 1.8 
W cm−2 (a–c). Temperature change of BSA-coated AuNRs aqueous solution at different Au concentration of 
0.0, 0.2, 0.4 and 0.6, 0.8 and 1.0 mM after NIR irradiation with different laser power intensity of 1.4, 1.6 and 
1.8 W cm−2 for 10 min (d). Data are presented as mean ± standard deviation, n = 3. No significant difference: 
N.S.; Significant difference: * p < 0.01, ** p < 0.01. 
Bovine serum albumin-coated AuNRs aqueous solution in medium at different Au concentration of 0.0, 
0.2, 0.4, 0.6, 0.8 and 1.0 mM was repeatedly irradiated for 5 cycles under continuous NIR irradiation at the 
laser power intensity of 1.6 W cm−2 for 10 min (Fig. 2.4). The heating curves (Fig. 2.4a) were almost the 
same for each cycle. Visible-near infrared absorption spectrum (Fig. 2.4b) and zeta potential (Fig. 2.4c) of 
BSA-coated AuNRs did not change before or after laser irradiation. The results suggested photothermal 
stability of the BSA-coated AuNRs during laser irradiation. 
Fig. 2.4 Temperature change curves of BSA-coated AuNRs aqueous solution in medium at different Au 
concentration of 0.0, 0.2, 0.4, 0.6, 0.8 and 1.0 mM over five laser on-off cycles (a). VIS-NIR spectrum (b) 
and Zeta potential (c) of BSA-coated AuNRs before laser irradiation and after five laser on-off cycles. The 
laser power intensity of 1.6 W cm-2 was used. Data are presented as mean ± standard deviation, n = 3. No 
significant difference: N.S. 
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2.4.3 Influence of BSA-Coated AuNRs on cell viability  
Cell viability decreased when Au concentration increased (Fig. 2.5). The 4T1-Luc cells cultured in 
medium containing BSA-AuNRs at an Au concentration of 0.6 mM still showed a high viability (85.0% 
compared to that of control group). However, when concentration of BSA-AuNRs increased to 0.8 and 1.0 
mM, cell viability decreased to 74.4 ± 10.8% and 57.1 ± 7.4%, respectively. For biomedical application, 
BSA-coated AuNRs as a photothermal conversion agent should have low toxicity to cells before laser 
irradiation. Cell ablation effect should be switched on only when laser irradiation is applied. Therefore, 
BSA-coated AuNRs at an Au concentration less than 0.6 mM were used to investigate photothermal ablation 
efficiency of tumor cells in the following experiment. 
 
Fig. 2.5 Cell viability of 4T1-Luc cells incubated in medium containing BSA-coated AuNRs at different Au 
concentrations (0.0 mM, 0.2 mM, 0.4 mM, 0.6 mM, 0.8 mM and 1.0 mM) for 1 day. Data are expressed with 
average ± standard deviation, n = 3. No significant difference: N.S.; significant difference: * p < 0.05.  
2.4.4 Cellular uptake of BSA-Coated AuNRs  
Cellular uptake amount of BSA-coated AuNRs was measured by ICP-OES (Fig2.6). The BSA-coated 
AuNRs were uptaken during cell culture. After 4T1-Luc cells were cultured in medium containing 
BSA-coated AuNRs at different gold concentration of 0.2, 0.4 and 0.6 mM for 6 h, the percentage of Au 
uptake was 5.1 ± 0.1%, 4.7 ± 0.3% and 4.2 ± 0.3%, respectively, which was not significantly different (Fig 
2.6 a). Cellular uptake amount of BSA-coated AuNRs was 7.5 ± 0.1 pg/cell, 11.8 ± 0.9 pg/cell and 21.9 ± 2.1 
pg/cell, respectively (Fig2.6 b). Cellular uptake amount of BSA-coated AuNRs significantly increased when 
Au concentration in the medium increased. 
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Fig. 2.6 Percentage of Au uptaken by 4T1-Luc cells (a) and cellular uptake amount of Au per cell (b) after 
being cultured in medium containing BSA-coated AuNRs at different Au concentration of 0.0, 0.2, 0.4 and 
0.6 mM for 6 h. Data are presented as mean ± standard deviation, n = 3. No significant difference: N.S.; 
Significant difference: ** p < 0.01; *** p < 0.001. 
2.4.5 Photothermal ablation effect of BSA-Coated AuNRs 
Photothermal ablation effect of BSA-coated AuNRs was evaluated by using calcein-AM/PI double 
staining kit and WST-1 assay. Live/dead staining images (Fig. 2.7 a–h) showed that after incubation with 
BSA-coated AuNRs at an gold concentration of 0.0, 0.2, 0.4 and 0.6 mmol/L for 6 h, most of the cells were 
live before laser irradiation. However, after laser irradiation for 10 min, a small portion of 4T1-Luc cells 
were dead in the group cultured with an Au concentration of 0.2 mM and almost all the tumor cells were 
dead in the groups cultured with an Au concentration of 0.4 and 0.6 mM. The cells of control group 
remained alive even after laser irradiation. In addition, quantification of cell viability (Fig. 2.7 i) showed that 
cell viability in the groups cultured with BSA-coated AuNRs at an gold concentration of 0.0, 0.2, 0.4 and 0.6 
mM decreased to 92.1 ± 9.3%, 80.4 ± 13.0%, 1.1 ± 3.3% and 1.0 ± 4.3%, respectively, after laser irradiation 
for 10 min. The results indicated that photothermal ablation effect of BSA-coated AuNRs increased with the 
increase of Au concentration. Incubation with BSA-coated AuNRs at an gold concentration of 0.4 and 0.6 
mM could ablate all the tumor cells by laser irradiation. 
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Fig. 2.7 Live/dead staining (a–h) and viability (i) of 4T1-Luc cells before and after NIR laser irradiation for 
10 min after the cells were cultured in medium containing BSA-coated AuNRs at different Au concentrations 
of 0.0, 0.2, 0.4 and 0.6 mM for 6 h. Green color indicates live cells while red color indicates dead cells. Data 
are presented as mean ± standard deviation, n = 3. No significant difference: N.S.; significant difference: * p 
< 0.05; *** p < 0.001. 
2.4.6 Immune responses of DCs triggered by photothermally ablated breast tumor cells 
Effects of soluble factors released from the ablated 4T1-Luc cells, direct cell–cell interaction and their 
combination on DCs were analyzed by using three different cell-culture models to distinguish these effects. 
Secretion of multiple cytokines including IL-6, IL-12, IL-1β and TNF-α from DCs was measured by ELISA 
Kit after transwell co-culture (diffusion model) or direct co-culture of immature DCs with the ablated breast 
tumor cells (cell contacting model) for 24 h. As shown in Fig. 2.8a-c, both cell–cell interaction and soluble 
factors released from ablated 4T1-Luc cells promoted the secretion level of IL-6, IL-12 and IL-1β as 
compared to those of negative control group. As for the secretion of TNF-α (Fig. 2.8d), only cell–cell 
interaction showed a promotive effect, while soluble factors released from the ablated 4T1-Luc cells could 
not promote TNF-α secretion as compared with the negative control group. 
 
Fig. 2.8 Secretion level of cytokines IL-6 (a), IL-12 (b), IL-1β (c) and TNF-α (d) by dendritic cells (DCs) 
after co-culture of immature DCs with photothermally ablated tumor cells under different co-culture models. 
Data are presented as mean ± standard deviation, n = 3. No significant difference: N.S.; significant 
difference: * p < 0.05; *** p < 0.001. 
2.5 Discussion 
Photothermal therapy using NIR light-responsive nanoparticles to ablate primary tumor has been widely 
studied [16, 40, 41]. However, it remains unclear if the ablated tumor cells can stimulate immune responses. In 
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this study, BSA-coated AuNRs were prepared and used to ablate tumor cells for investigation of the interaction 
between ablated tumor cells and immune cells. Photothermal ablation efficiency towards breast tumor cells 
after cellular uptake of BSA-coated AuNRs and immune-stimulatory response of DCs triggered by ablated 
breast tumor cells were investigated. 
Gold nanorods were synthesized by a seed-mediated growth method. They were further coated with BSA 
for good colloid stability and biocompatibility. The BSA-coated AuNRs had a rod-like morphology and 
showed a strong SPR adsorption peak at 848 nm corresponding to their longitudinal plasmon modes, which 
indicated AuNRs could be used as a photothermal conversion agent. The heating curve and temperature 
change induced by NIR laser irradiation could be modulated by changing the concentration of AuNRs and 
laser power intensity, which indicated that BSA-coated AuNRs had an excellent photothermal performance. 
Moreover, heating curves from five cycles of laser on/off suggested BSA-coated AuNRs had excellent 
photothermal stability. 
The BSA-coated AuNRs possessed low cytotoxicity in a broad Au concentration range of 0.0~0.6 mM. In 
this study, an Au concentration of 0.4 mM was used for photothermal ablation experiments. If gold 
nanoparticles are hybridized with other matrices, the amount of gold nanoparticles can be further increased 
[42]. Hybridization of various nanoparticles with polymer matrices has been used to increase 
biocompatibility of nanoparticles for controlling cell functions [19, 38]. In this study, after the breast tumor 
cells were cultured with BSA-coated AuNRs, BSA-coated AuNRs could be uptaken by tumor cells and the 
cellular uptake amount increased significantly with the increase of AuNRs concentration in culture medium, 
which should be beneficial for photothermal ablation. The breast tumor cells could be efficiently ablated by the 
uptaken BSA-coated AuNRs after NIR laser irradiation when the Au concentration in cell culture medium was 
0.4 and 0.6 mM. At a low gold concentration of 0.2 mM, the BSA-coated AuNRs could partially ablate the 
breast tumor cells. When Au concentration was higher, more AuNRs were uptaken by cells and more rapid 
heating and higher temperatures could be reached to ablate tumor cells. 
To investigate whether the photothermally ablated tumor cells could induce immune response, immature 
DCs as a key antigen-presenting cells [43] were directly co-cultured with photothermally ablated tumor cells 
for 24 h. Moreover, to determine whether soluble factors released from photothermally ablated tumor cells 
were involved in DCs maturation, immature DCs and photothermally ablated tumor cells were co-cultured in a 
diffusion model, which enabled diffusion of soluble factor in the culture medium while blocking direct 
cell-to-cell contact. When DCs are matured, they can increased the secretion amount of cytokines to induce 
the activation of immune cells such as T lymphocyte, which plays crucial roles in inducing the immune 
responses [44]. IL-6, IL-12 and IL-1β are typical markers of humoral immunity [33] and TNF-α is a typical 
marker of cellular immunity [33, 45]. Secretion of IL-6, IL-12 and IL-1β was promoted by both cell–cell 
interaction (cell contact) and soluble factors, while secretion of TNF-α was only promoted by cell-cell 
interaction. The results suggested that photothermally ablated tumor cells by BSA-coated AuNRs were able to 
induce immune responses of DCs, which should be useful for cancer immunotherapy. 
2.6 Conclusions 
Gold nanorods were prepared by a seed-mediated growth method and coated with BSA for 
photothermal ablation of breast tumor cells. The BSA-coated AuNRs showed good monodispersity, low 
cytotoxicity as well as high cellular uptake by tumor cells in the studied concentration. The BSA-coated 
AuNRs showed excellent photothermal performance based on the strong SPR absorption in NIR region and 
showed high photothermal ablating efficiency towards breast tumor cells. Moreover, the photothermally 
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ablated tumor cells triggered immune-stimulatory responses of immature DCs through both cell–cell 
interaction and soluble factors released from the ablated tumor cells. 
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3.1 Summary 
Breast cancer is a major public health issue, whose morbidity and mortality are increasing across the 
world. It is still a challenge to completely ablate breast tumor cells by nanoparticles-mediated photothermal 
therapy. Photothermal scaffolds by incorporating photothermal nano-agents into porous scaffold are a 
desirable option to achieve the effect. In this study, composite porous scaffolds of gold nanorods (AuNRs) 
and gelatin with well controlled pore structures were prepared by introducing AuNRs into the porous 
matrices of gelatin and mixing with ice particles as a template. The AuNRs-gelatin composite scaffolds 
demonstrated high photothermal conversion effect, whose photothermal temperature could be modulated by 
the amount of incorporated AuNRs, NIR laser power intensity and irradiation time. The AuNRs-gelatin 
composite scaffolds exhibited excellent photothermal ablation capacity of breast tumor cells in vitro and in 
vivo. Furthermore, photothermally ablated tumor cells also induced activation of DCs by co-culture with 
immature DCs and ablated tumor cells in AuNRs-gelatin scaffolds. 
3.2 Introduction 
Breast cancer becomes one of the major threats to human life due to its increasing morbidity 
and mortality [1, 2]. Until now, surgery, chemo- or radio-therapy and their combination have been 
widely applied to treat breast tumor in clinic [3-6]. However, surgical resection cannot completely 
remove all the tumor cells [7]. Chemotherapy and radiotherapy can give rise to adverse effects such 
as drug-resistance and radio-resistance [8-10].  
In recent years, photothermal therapy (PTT), as a minimally invasive and highly efficient 
antitumor strategy, has attracted great attention [11, 12]. Various photothermal conversion agents 
such as carbon-based nanomaterials, copper sulfide nanoparticles and gold-based nanomaterials have 
been extensively explored [13-16]. Among them, gold nanoparticles, especially gold nanorods 
(AuNRs), have raised much attention due to their tunable surface plasmon resonance property and 
facile preparation and good cytocompatibility [17-19]. However, efficacious and site-specific 
delivery of free nanoparticles to tumor site still has some problems [20-22]. Upon intravenous 
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injections of nanoparticles, the nanoparticles (NPs) undergo uptake by macrophages of mononuclear 
phagocyte system, which results in high accumulation of NPs in healthy organs such as liver and 
spleen [23-25]. To address these issues, immobilization of PTT NPs into three-dimensional (3D) 
scaffolds has been recently explored to realize repeat heating and local tumor therapy [26-29]. 
Based on the above consideration, functional composite scaffold of AuNRs and gelatin were 
fabricated by incorporating AuNRs in gelatin matrices through a freeze-drying method in this study. 
Pre-prepared ice particulates with optimized size were used as a template and mixed with 
AuNRs/gelatin mixture solution to control the pore structures of the composite scaffolds. 
Photothermal performance of the composite scaffolds under near infrared (NIR) laser at various 
power intensities was investigated. Their photothermal killing efficiency of breast tumor cells was 
evaluated by in vitro cell culture and in vivo animal experiment. Moreover, the effects of 
photothermally ablated tumor cells in AuNRs-gelatin composite scaffolds on the activation of 
dendritic cells were also investigated by co-culture with immature DCs and ablated tumor cells in 
AuNRs-gelatin scaffolds. 
3.3 Materials and methods 
3.3.1 Synthesis and characterization of gelatin-stabilized AuNRs 
AuNRs were synthesized by a seed-mediated growth method [30, 31]. First gold seed solution were 
obtained via the reaction of hydrogen tetrachloroaurate(Ⅲ) tetrahydrate (HAuCl4•4H2O, Wako) and sodium 
borohydride (NaBH4, Sigma) in hexadecyltrimethylammonium bromide (CTAB, 0.1 mol/L, 7.5 mL) aqueous 
solution. The prepared Au seeds were used within 2 hours. Subsequently, a growth solution was obtained by 
mixing CTAB (0.1 mol/L, 100.0 mL) solution with HAuCl4 (0.01 mol/L, 5.0 mL), HCl (1 mol/L, 2.0 mL), 
AgNO3 (0.01 mol/L, 1.1 mL) and ascorbic acid (0.1 mol/L, 0.8 mL) solutions in sequence. Finally, the 
pre-prepared gold seeds grew up along the silver crystal in the growth solution under gentle stirring for 12 h 
to allow the formation of AuNRs. The AuNRs were collected by centrifugation under 8000 rpm for 10 min. 
In order to remove the CTAB, the collected AuNRs were washed with ultrapure water. 
In order to avoid agglomeration of AuNRs and to make the homogeneously distributed AuNRs 
suspension in ultrapure water, the AuNRs were coated with gelatin by dispersing them into 0.5% (w/v) 
gelatin solution under stirring for 24 hours. The gelatin-coated AuNRs were obtained by centrifugation. The 
gelatin-coated AuNRs were resuspended in ultrapure water for the following experiments. 
The morphology of gelatin-coated AuNRs was characterized with a transmission electron microscope 
(TEM, JEOL 2011F, Japan). The size of AuNRs was measured from TEM images with a ImageJ software 
(ImageJ2, NIH). Visible-near infrared (VIS−NIR) spectrum of aqueous solution of AuNRs was measured 
with a UV-660 UV-VIS spectrophotometer (Jasco Corp., Japan)  
3.3.2 Preparation and characterization of AuNRs–gelatin composite scaffolds 
AuNRs-gelatin composite porous scaffolds were prepared by freeze-drying the mixture solution of 
gelatin-coated AuNRs, gelatin and pre-prepared ice particulates as previously reported [32, 33]. Briefly, the 
ultrapure water were sprayed into liquid nitrogen to prepare the ice particles. Then the proper size (between 
425 μm and 500 μm) of pre-prepared ice particles was optimized by sieving the ice particles with two 
meshes. Subsequently, A 70% acetic acid solution of 8 (w/v) % gelatin was mixed with 4.0 or 8.0 mM 
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AuNRs solution at a ratio of 1:1 (v/v) under sonication to prepare AuNRs/gelatin mixture solutions. The final 
concentration of gelatin in the mixture solutions was 4 (w/v) % while AuNRs concentration was 2.0 and 4.0 
mM because our previous study showed that these two concentrations had good heating effect. The ice 
particulates, gelatin aqueous solution and AuNRs/gelatin mixture solution were kept in the chamber setting 
the temperature of -4 °C for 6 hours to balance. Subsequently, 7.0 g ice particles were homogenously mixed 
with 3 mL AuNRs-gelatin mixture solution. The mixture of ice particulates and AuNRs-gelatin solution was 
poured into a silicone mold. Finally, the whole constructs were transferred into -20 °C freezer for 12 hours 
and then moved to a -80 °C freezer for 4 hours. After that, the constructs were transferred into the 
freeze-dryer (FDU-2200, Japan) for freeze-drying to obtain the porous scaffolds. Then the AuNRs-gelatin 
porous composite scaffolds were chemically cross-linked using 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide and N-hydroxysuccimide (EDC/NHS) to obtain the AuNRs-gelatin composite porous scaffolds. 
The morphology of AuNRs-gelatin composite scaffolds was characterized with a field emission scanning 
electron microscope (FESEM: SU8220, Hitachi, Japan). The AuNRs-gelatin composite scaffold prepared 
with an AuNRs concentration of 2.0 and 4.0 mM was defined as 2.0 mM AuNRs-gelatin scaffold and 4.0 
mM AuNRs-gelatin scaffold, respectively. Gelatin scaffold without incorporation of AuNRs was also 
prepared as a control with the above-mentioned procedures without addition of AuNRs. 
Pore size of gelatin scaffold and AuNRs-gelatin composite scaffolds was analyzed by measuring the 
diameters of pores in SEM images by Image-J software. The photothermal performance of gelatin scaffold, 
2.0 mM AuNRs-gelatin scaffold and 4.0 mM AuNRs-gelatin scaffold was investigated by irradiation with an 
805 nm laser (Thorlabs Inc., USA). Briefly, the AuNRs-gelatin composite scaffolds (5.0 ×3.0 ×1.0 mm) were 
immersed with culture medium. Then the hydrated samples were placed in culture plate and irradiated with 
near infrared laser at the wavelength of 805 nm. The temperature change of the AuNRs-gelatin composite 
scaffolds under NIR laser irradiation with different power intensity (1.3, 1.4, 1.5 or 1.6 W/cm2) was recorded 
by a digital thermometer (As one Corp., Osaka, Japan) in real time. 
3.3.3 Photothermal ablation of in vitro cultured breast tumor cells in AuNRs–gelatin 
scaffolds 
The AuNRs-gelatin composite porous scaffolds (5.0 ×3.0 ×1.0 mm) were immersed in 70% ethanol 
solution for 4 h and washed with PBS for 6 times to sterilization. Human breast tumor cells that stably 
express luciferase (MDA-MB231-Luc) were obtained from Japanese collection of research bioresources cell 
bank (Osaka, Japan). MDA-MB231-Luc cells were cultured in L-15 medium supplemented with 15 % FBS. 
When the cells proliferated to 80% in the flask, the medium was removed and washed with PBS. Then 
0.25% trypsin solution was added into flask and incubated for 5 min to detach the cells from the surface of 
flask. The harvested 4T1-Luc cells were re-suspended in L-15 medium and used for following experiments. 
Subsequently, 15 µL of the cell suspension solution was dropped into both two side of the scaffold cubes. 
The cell/scaffold constructs were transferred to a 24-well culture plate with 1 mL L-15 medium in each well. 
After culture of breast tumor cells in AuNRs-gelatin composite porous scaffolds for 24 h, the 
cells/scaffold were removed from medium and exposed under NIR laser (805 nm) irradiation at different 
power intensity (1.3 or 1.6 W/cm2). After that, the breast tumor cells in the composite scaffolds were 
incubated for 5 hours for live/dead cell staining. Then the live and dead cells in the composite scaffolds 
before and after laser irradiation were stained by calcein-AM/PI double staining kit (Dojindo, Japan) and 
then imaged under an inverted fluorescence microscope (Olympus, Japan). In addition, cell viability in the 
scaffolds before and after irradiation with a power intensity of 1.3 or 1.6 W/cm2 for 3, 5, 6 and 8 minutes was 
quantified by WST-1 assay. 400 μL WST-1 reagent diluted by medium (1: 10) was added into each well 
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containing the cell/scaffold constructs and incubated for 3 hours. And then, the absorbance of WST-1 
solution was detected via a microplate reader at the wavelength of 440 nm. The mean and standard deviation 
were calculated through three parallel samples of each group. 
3.3.4 Activation of dendritic cells by co-culture with immature DCs and ablated tumor cells 
in AuNRs-gelatin composite scaffolds 
The 4T1-Luc cells (2 × 105 cells/scaffold) were seeded on the 2.0 mM AuNRs-gelatin composite 
scaffold (5.0 ×3.0 ×1.0 mm) and cultured for 48 h. After that, the 4T1-Luc/AuNRs-gelatin scaffold was taken 
out from medium and the residual medium inside of scaffolds was absorbed using sterile tissue. Subsequently, 
the 4T1-Luc/AuNRs-gelatin scaffold construct was transferred into 96-well culture plate and irradiated with 
an 805 nm laser at a power intensity of 1.6 W cm−2 to photothermally ablate tumor cells.  
Mouse bone marrow-derived immature dendritic cells (DCs, ATCC, Manassas, Virginia, USA) were 
used to investigate immune responses induced by photothermally ablated tumor cells in AuNRs-gelatin 
composite scaffold. Briefly, DCs (1 × 105 cells/scaffold) were seeded on the ablated 4T1-Luc/AuNRs-gelatin 
scaffold construct after photothermal ablation of tumor cells and cultured in MEM-α medium with 5 ng/mL 
GM-CSF for 36 h. As for control group, DCs (1 × 105 cells/scaffold) were seeded on the live 
4T1-Luc/AuNRs-gelatin scaffold construct without laser irradiation and cultured for 36 h. As positive and 
negative controls, DCs (1 × 105 cells/scaffold) were directly seeded in 2.0 mM AuNRs-gelatin composite 
scaffold and cultured with or without 1 μg/mL lipopolysaccharide (LPS) stimulation for 36 h. Finally, 
supernatants were harvested to measure the secretion amount of interleukin 6 (IL-6), interleukin 12 (IL-10), 
interleukin 1β (IL-1β) and tumor necrosis factor alpha (TNF-α) by an enzyme-linked immunosorbent assay 
(ELISA) kit according to the manufacturer’s instructions (PEPROTECH, Rocky Hill, New Jersey, USA). 
Mean and standard deviation were calculated by performing three parallel samples for each group. 
3.3.5 Photothermal ablation of in vivo implanted breast tumor cells by AuNRs–gelatin 
scaffolds 
The MDA-MB231-Luc cells were seeded in the cubes (5.0 ×3.0 ×1.0 mm) of gelatin porous scaffold 
and 2.0 mM AuNRs-gelatin scaffold and cultured in vitro for 3 days. The tumor cells/scaffold constructs 
were subcutaneously implanted into the back of 6-week-old female athymic nude mice. The nude mice were 
divided into four groups: tumor cells/gelatin scaffold, tumor cells/AuNRs-gelatin scaffold, tumor 
cells/gelatin scaffold + NIR laser irradiation, tumor cells/ AuNRs-gelatin scaffold + NIR laser irradiation. 
After implantation for 6 days, the implantation sites of the mice were irradiated with an NIR laser (805 nm) 
at a power density of 1.3 W/cm2 for 10 minutes and 1.6 W/cm2 for 8 minutes. After 1 day, the whole-body 
bioluminescence image was taken with an in vivo vision system (IVIS Lumina II, Japan) to evaluate the in 
vivo photothermal ablation effect of 2.0 mM AuNRs-gelatin scaffold. The procedures of animal experiments 
were supported by the Animal Experiments Committee and then the experiments were carried out according 
to the committee’s guideline. 
3.3.6 Statistical analysis 
The quantitative experiment in this study was repeated using three parallel samples and the results were 
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expressed with average ± standard deviation (SD). The statistical analysis including significant difference 
was carried out by one-way ANOVA analysis software. The p value of 0.05 was considered statistically 
significant difference. The data were classified according to their p values and denoted by (*) for p less than 
0.05, (**) for p less than 0.01 and (***) for p less than 0.001.  
3.4  Results 
3.4.1 Physical and chemical properties of gelatin-stabilized AuNRs 
The gross appearance of colloid solution of AuNRs (Fig. 3.1a) showed that the gelatin-coated gold 
nanoparticles were homogeneously dispersed in pure water without aggregation. TEM images (Fig. 3.1b and 
c) indicated that gold nanoparticles were uniformly distributed without aggregation and had a rod-like shape 
with a dimension of 66.1 ± 2.3 nm × 13.6 ± 2.5 nm. The visible-near infrared (VIS-NIR) absorption 
spectrum (Fig. 3.1d) showed that AuNRs had a strong absorption peak in near infrared region, which is 
beneficial for photothermal therapy. 
 
Fig. 3.1 Gross appearance of colloid solution of gelatin-coated AuNRs in pure water (a), TEM images of 
AuNRs at low (b) and high (c) magnifications and VIS-NIR spectrum of AuNRs colloid solution (d). 
3.4.2 Characterization of AuNRs–gelatin composite scaffolds 
SEM observation showed that the AuNRs-gelatin composite scaffolds had spherical large micropores 
with good interconnectivity, which were the same as those of the gelatin porous scaffold (Fig. 3.2a, b and c). 
Observation at a high magnification showed that AuNRs were individually distributed on the micropore wall 
of the composite scaffolds (Fig. 3.2e and f). No AuNRs were observed in the gelatin scaffold (Fig. 3.2d). 
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Fig. 3.2 SEM images of gelatin scaffold (a, d), 2.0 mM AuNRs-gelatin scaffold (b, e) and 4.0 mM 
AuNRs-gelatin scaffold (c, f) at a low magnification (a-c) and a high magnification (d-f). S1, S2 and S3 
indicate gelatin scaffold, 2.0 mM AuNRs-gelatin scaffold and 4.0 mM AuNRs-gelatin scaffold, respectively. 
The insets show the magnified images of the corresponded scaffold. 
3.4.3 Photothermal performance of AuNRs–gelatin composite scaffolds 
Temperature of AuNRs-gelatin scaffolds increased when the scaffolds were irradiated with a NIR laser 
of 805 nm (Fig. 3.3). The photothermal temperature of AuNRs-gelatin scaffolds could be effectively 
modulated by changing the laser power intensity and altering the AuNRs amount. The AuNRs-gelatin 
scaffolds showed different photothermal efficiency under a variable laser power intensity (Fig. 3.3a and 3.b). 
Higher laser power intensity resulted in higher temperature. The temperature change data (Table 3.1) 
indicated that temperature change of gelatin scaffold, 2.0 mM AuNRs/gelatin scaffold and 4.0 mM. 
AuNRs/gelatin scaffold was 4.4 ± 0.9 ~8.9 ± 0.7 oC, 23.2 ± 0.8~32.9 ± 0.9 oC and 28.1 ± 0.9 ~41.0 ± 1.0 oC, 
respectively, when the laser power intensity varied from 1.3 W/cm2 to 1.6 W/cm2. When different scaffolds 
were compared, temperature change of gelatin scaffold under NIR laser irradiation was very slow while that 
of AuNRs-gelatin scaffolds increased rapidly (Fig. 3.3c and 3.3d). The temperature of 4.0 mM 
AuNRs-gelatin scaffolds was higher than that of 2.0 mM AuNRs-gelatin scaffolds under the same powder 
density, which indicated that increase of the incorporated AuNRs amount enhanced photothermal conversion 
efficiency of the composite scaffolds. 
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Fig. 3.3 Heating curves of AuNRs-gelatin composite scaffolds under continuous irradiation with 805 nm 
laser. Temperature-irradiation time curves of 2.0 mM AuNRs-gelatin scaffold (a) and 4.0 mM AuNRs-gelatin 
scaffold (b) under NIR laser irradiation at a power density of 1.3, 1.4, 1.5 and 1.6 W/cm2. 
Temperature-irradiation time curves of gelatin scaffold, 2.0 mM AuNRs-gelatin scaffold and 4.0 mM 
AuNRs-gelatin scaffold under NIR laser irradiation at a power intensity of 1.3 W/cm2 (c) and 1.6 W/cm2 (d). 
S1, S2 and S3 indicate gelatin scaffold, 2.0 mM AuNRs-gelatin scaffold and 4.0 mM AuNRs-gelatin scaffold, 
respectively. 
 
Table 3.1 Temperature change (oC) of gelatin scaffold (S1), 2.0 mM AuNRs-gelatin scaffold (S2) and 4.0 
mM AuNRs-gelatin scaffold (S3) after irradiation at different laser power densities for 10 minutes 
3.4.4 Photothermal ablation effect of AuNRs–gelatin composite scaffolds towards breast 
tumor cells in vitro 
The photothermal ablation of breast tumor cells cultured in AuNRs-gelatin scaffolds was explored by 
NIR laser irradiation with the power density of 1.3 and 1.6 W/cm2. Live/dead staining showed that almost all 
the tumor cells were live within the porous scaffolds before NIR laser irradiation (Fig. 3.4 a-c). After laser 
irradiation at the laser power intensity of 1.3 W/cm2 for 8 minutes and 1.6 W/cm2 for 6 minutes, almost all 
the breast tumor cells were dead in the AuNRs-gelatin composite scaffolds, while the breast tumor cells still 
kept alive in the gelatin scaffolds (Fig. 3.4 d-i). Quantification of cell viability showed that cellular viability 
of MDA-MB231-Luc cells cultured in gelatin scaffold had no significant change before and after NIR laser 
irradiation, while cellular viability in AuNRs-gelatin composite scaffolds significantly decreased after NIR 
laser irradiation (Fig. 3.4 j and k). Cell viability in AuNRs-gelatin composite scaffolds significantly 
decreased after NIR laser irradiation. Increase of irradiation time significantly decreased cell viability. Cell 
viability of MDA-MB231-Luc cells cultured in 2.0 mM AuNRs-gelatin scaffold and 4.0 mM AuNRs-gelatin 
scaffold decreased to 0% after NIR laser irradiation at the power density of 1.3 W/cm2 for 8 minutes or 1.6 
W/cm2 for 6 minutes. Increase of NIR laser density resulted in further decrease of cell viability. Under the 
same NIR laser irradiation condition, cells cultured in 4.0 mM AuNRs-gelatin scaffold showed quicker 
decrease of viability than did those cultured in 2.0 mM AuNRs-gelatin scaffold, suggesting that increase of 
AuNRs raised the photothermal killing effect of tumor cells. 
           Sample 
 
Power density 
S1 S2 S3 
1.3 W/cm2 
1.4 W/cm2 
1.5 W/cm2 
1.6 W/cm2 
4.4 ± 0.9 
6.9 ± 0.6 
7.9 ± 0.5 
8.9 ± 0.7 
23.2 ± 0.8 
26.6 ± 1.1 
29.6 ± 0.7 
32.9 ± 0.9 
28.1 ± 0.9 
33.5 ± 1.3 
38.0 ± 1.4 
41.0 ± 1.0 
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Fig. 3.4 Live/dead staining of breast tumor cells (MDA-MB231-Luc cells) cultured in gelatin scaffold (a, d, 
g), 2.0 mM AuNRs-gelatin scaffold (b, e, h) and 4.0 mM AuNRs-gelatin scaffold (c, f, i) without (a-c) and 
with NIR laser irradiation (d-i) at a laser power intensity of 1.3 W/cm2 for 8 minutes (d-f) and a laser power 
intensity of 1.6 W/cm2 for 6 minutes (g-i). Green color displays live cells stained by calcein-AM while red 
color displays dead cells stained by PI. Viability of MDA-MB231-Luc cells cultured in gelatin scaffold and 
AuNRs-gelatin composite scaffolds after irradiation for different time with a laser power intensity of 1.3 
W/cm2 (j) and 1.6 W/cm2 (k). S1, S2 and S3 indicate gelatin scaffold, 2.0 mM AuNRs-gelatin scaffold and 
4.0 mM AuNRs-gelatin scaffold, respectively. The data are displayed as average ± standard deviation, n = 3. 
No significant difference: N.S.; significant difference: * p < 0.05; ** p < 0.01; *** p < 0.001. 
3.4.5 Activation of dendritic cells by photothermally ablated cells in AuNRs–gelatin 
composite scaffolds  
SEM images (Fig. 3.5) demonstrated that before laser irradiation, the breast tumor cells were attached 
well on the wall of micropores in 2.0 mM AuNRs-gelatin composite scaffolds. And the tumor cells 
distributed throughout the scaffolds. Moreover, the ablated tumor cells still remained in the AuNRs-gelatin 
composite scaffolds after laser irradiation, which will induce the activation of DCs when co-culture of 
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immature DCs and photothermally ablated tumor cells in the AuNRs-gelatin composite scaffolds. 
To investigate the activation of DCs by photothermally ablated tumor cells in AuNRs-gelatin composite 
scaffolds, secretion of multiple cytokines including IL-6, IL-10, IL-1β and TNF-α from DCs was measured 
by ELISA Kit after co-culture of immature DCs and ablated tumor cells in AuNRs-gelatin composite 
scaffolds for 36 h. As shown in Fig. 3.6, the ablated tumor cells including cell debris and soluble factors 
promoted the secretion level of IL-6, IL-10, IL-1β and TNF-α as compared to those of live tumor cells. 
Moreover, the live tumor cells promoted the secretion level of IL-6 and IL-1β in comparation with those of 
negative control group. 
Fig. 3.5 Breast tumor cells morphology in 2.0 mM AuNRs-gelatin composite scaffold before and after laser 
irradiation at a laser density of 1.6 W/cm2. 
Fig. 3.6 Secretion level of cytokines IL-6 (a), IL-10 (b), IL-1β (c) and TNF-α (d) by dendritic cells (DCs) 
after co-culture of immature DCs and photothermally ablated tumor cells in 2.0 mM AuNRs-gelatin 
composite scaffold. Data are presented as mean ± standard deviation, n = 3. No significant difference: N.S.; 
significant difference: * p < 0.05; ** p < 0.01; *** p < 0.001. 
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3.4.6 Photothermal ablation of breast tumor cells by AuNRs–gelatin composite scaffolds in 
vivo 
The in vivo photothermal ablation effect of breast tumor cells by AuNRs-gelatin scaffold was evaluated 
by the whole-body bioluminescence imaging after laser irradiation. MDA-MB-231-Luc cells were cultured 
in gelatin scaffold and 2.0 mM AuNRs-gelatin scaffold in vitro. Then the MDA-MB-231-Luc cells/ 
AuNRs-gelatin scaffold construct was subcutaneously implanted on the back of nude mice. After 6 days 
implantation, the implantation sites of the mice were irradiated with an NIR laser. Bioluminescent images 
showed that the bioluminescent signal of living MDA-MB231-Luc cells in 2.0 mM AuNRs-gelatin scaffold 
evidently decreased after NIR laser irradiation, while that in gelatin scaffolds kept almost unchanged (Fig. 
3.7). Irradiation at the laser power density of 1.6 W cm-2 for 8 minutes showed almost the same effect as that 
of irradiation at a laser power density of 1.3 W cm-2 for 10 minutes. The results indicated that most of the 
breast cancer cells were killed by 2.0 mM AuNRs-gelatin scaffold under NIR laser irradiation. Gross 
appearance of the mice showed that the skin tissue near the implanted 2.0 mM AuNRs-gelatin scaffold was 
obviously damaged after NIR laser irradiation at the high power intensity (1.6 W cm-2) for 8 minutes (Fig. 
3.8). Skin damage was suppressed when the irradiation was conducted at the laser power density of 1.3 W 
cm-2 for 10 minutes. 
 
Fig. 3.7 Whole-body bioluminescence imaging of mice subcutaneously implanted with MDA-MB231-Luc 
cells/gelatin scaffold and MDA-MB231-Luc cells/2.0 mM AuNRs-gelatin scaffold constructs before 
irradiation (a, c) and after NIR laser irradiation at a laser density of 1.6 W/cm2 for 8 minutes (b) and a laser 
density of 1.3 W/cm2 for 10 minutes (d). S1 and S2 indicate gelatin scaffold and 2.0 mM AuNRs-gelatin 
scaffold, respectively. 
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Fig. 3.8 Photographs of mice subcutaneously implanted with MDA-MB231-Luc cells/gelatin scaffold and 
MDA-MB231-Luc cells/2.0 mM AuNRs-gelatin scaffold constructs before irradiation (a, c) and after NIR 
laser irradiation at a laser density of 1.6 W/cm2 for 8 minutes (b) and a laser density of 1.3 W/cm2 for 10 
minutes (d). 
3.5  Discussions 
Complete ablation of residual breast tumor cells to prevent tumor recurrence still remains a critical 
challenge in breast cancer therapy [34-36]. To address these issues, AuNRs-gelatin composite porous 
scaffolds were designed and prepared by incorporating photothermal conversion nanoparticles, AuNRs, in 
gelatin porous scaffold. AuNRs aqueous solutions at a different concentration of AuNRs (2.0, 4.0 mM) were 
used to introduce different amount of AuNRs in the composite scaffolds. Optimized ice particles were 
applied as a template material to regulate the pore structure of composite scaffold. The composite scaffolds 
had the same size of spherical large micropores and small micropores as those of gelatin scaffold (Fig. 
3.2a-c). 
The synthesized AuNRs had a strong near-infrared light absorption peaks at a wavelength of 813 nm 
(Fig. 3.1d), which is skin-penetrative, non-invasive and harmless [37, 38]. AuNRs-gelatin composite 
scaffolds showed excellent photothermal performance under the NIR (805 nm) irradiation (Fig. 3.3 and Table 
3.1). The photothermal conversion of composite scaffolds should be due to the photothermal conversion 
property of AuNRs. It has been reported that AuNRs can efficiently convert near infrared light into heat [39]. 
The photothermal-induced temperature changes of the AuNRs-gelatin composite scaffolds could be 
modulated by changing the laser power intensity, irradiation time and incorporated AuNRs amount.  
The excellent photothermal performance of AuNRs-gelatin composite scaffolds was applied for 
photothermal ablation of breast tumor cells. The in vitro cell culture and in vivo animal experiment showed 
that the composite scaffolds could effectively kill breast tumor cells (Fig. 3.4 and 3.7). Composite scaffolds 
prepared with different concentration of AuNRs (2.0 mM and 4.0 mM) were used for the ablation of tumor 
cells to examine the effect of AuNRs amount. The in vitro cell culture experiments indicated that the two 
composite scaffolds could effectively kill tumor cells and the killing effect increased with the increase of 
incorporated AuNRs amount, NIR laser intensity and irradiation time (Fig. 3.4). The dependence of tumor 
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cell ablation capacity on AuNRs amount, NIR laser intensity and irradiation time should be due to the 
heating characteristics of AuNRs incorporated in the composite scaffolds. Because both 2.0 mM and 4.0 mM 
AuNRs-gelatin scaffolds could kill all the breast tumor cells after NIR laser irradiation at the power density 
of 1.3 W cm-2 for 8 minutes and the power density of 1.6 W cm-2 for 6 minutes, 2.0 mM AuNRs-gelatin 
scaffold was used for in vivo animal experiments. Moreover, the ablated tumor cells still remained in the 
AuNRs-gelatin composite scaffolds after laser irradiation as shown in Fig. 3.5. These ablated tumor cells also 
promoted the secretion level of multiple cytokines (Fig. 3.6) including IL-6, IL-10, IL-1β and TNF-α from 
DCs after co-culture of immature DCs and ablated tumor cells in AuNRs-gelatin scaffold, which might 
triggers the immune system to prevent tumor metastasis and recurrence.   
For in vivo animal experiment, MDA-MB231-Luc cells were seeded in the scaffolds and then 
subcutaneously implanted in nude mice. The seeded cells could be thought as migrated cells from 
surrounding tissues and this model was used to confirm the killing effect of composite scaffolds on the 
migrated cells. NIR laser irradiations at the power density of 1.3 W/cm2 for 10 minutes and a power intensity 
of 1.6 W/cm2 for 8 minutes were used to guarantee the killing effect. The whole-body bioluminescent images 
showed that the luminescence intensity, which indicated living cells, decreased dramatically after NIR laser 
irradiation of the 2.0 mM AuNRs-gelatin scaffold (Fig. 3.7). The results indicated that most of breast cancer 
cells were killed by photothermal ablation of 2.0 mM AuNRs-gelatin composite scaffolds. Both irradiation 
conditions at the power density of 1.3 W/cm2 for 10 minutes and a power intensity of 1.6 W/cm2 for 8 
minutes showed dramatic ablation effects. However, the skin tissue near the 2.0 mM AuNRs-gelatin 
scaffolds was obviously damaged after laser irradiation at a high power density (1.6 W cm-2 for 8 minutes) 
(Fig. 3.8). Therefore, achieving effective tumor ablation under relative low photothermal temperature is 
critical toward successful clinical application of PTT [40]. 
3.6  Conclusions 
AuNRs-gelatin porous scaffolds were prepared by introducing AuNRs in the porous structure of gelatin 
matrices via a freeze-drying method. Pre-prepared ice particulates with optimized size were used as a 
template to construct the pore structure of scaffolds. The AuNRs-gelatin composite scaffolds showed high 
photothermal conversion efficiency. The AuNRs-gelatin composite scaffolds also showed excellent 
photothermal ablation capacity of breast tumor cells in vitro and in vivo. Furthermore, photothermally 
ablated tumor cells also induced activation of DCs by co-culture of immature DCs and ablated tumor cells in 
AuNRs-gelatin composite scaffolds, which might triggers the immune system to prevent tumor metastasis 
and recurrence.  
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Adipogenic differentiation of hMSCs in AuNRs-gelatin composite 
scaffolds 
 
 
 
 
4.1 Summary 
Breast cancer is a major public health issue, whose morbidity and mortality are increasing across the 
world. It is still a challenge to reconstruct tumor-initiated breast defects after surgical resection. Porous 
scaffolds with hyperthermal and tissue regeneration functions are a desirable option to achieve the effects. In 
this study, composite porous scaffolds of gold nanorods (AuNRs) and gelatin with well controlled pore 
structures were prepared by introducing AuNRs into the porous matrices of gelatin and mixing with ice 
particles as a template. The AuNRs-gelatin porous scaffolds supported cell adhesion and promoted 
proliferation and adipogenic differentiation of human bone-marrow derived mesenchymal stem cells 
(hMSCs). Consequently, the AuNRs-gelatin scaffold has a potential of breast reconstruction by promoting 
adipogenic differentiation of stem cells for adipose tissue regeneration. 
4.2 Introduction 
Breast cancer becomes one of the major threats to human life due to its increasing morbidity 
and mortality [1, 2]. Until now, surgery, chemo- or radio-therapy and their combination have been 
widely applied to treat breast tumor in clinic [3-5]. However, large breast defect is always 
accompanied with cancer removal, which is difficult to self-heal [6]. Until now, it still remains a big 
challenge to realize breast reconstruction after tumor therapy [7, 8]. Therefore, it is expected to 
design highly functional biomaterials that can be used to promote breast reconstruction as bioactive 
scaffolds [9-13]. 
It has been reported that adipose tissue can be regenerated by combining a 3D biodegradable 
porous scaffold with adipose-derived stromal cells or bone-marrow derived mesenchymal stem cells 
[12, 14]. 3D scaffold for adipose tissue engineering should bear soft tissue-like mechanical property, 
biocompatibility and biodegradability [14-18]. Gelatin has been used for preparation of tissue 
regeneration scaffolds because of its high bioactivity, low antigenicity and low immunogenicity [19, 
20]. Gelatin scaffold has been reported favorable for adipose tissue engineering because of its soft 
tissue-like mechanical property, as compared to stiff scaffold such as poly lactic-co-glycolic acid 
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scaffold [14, 21-23]. In addition, 3D scaffolds should have an appropriate pore structure with open 
and interconnected pores to promote cell penetration and nutrition and metabolite exchange [24]. 
Although a variety of methods have been explored to fabricate porous scaffolds such as 
electrospinning, 3D printing and porogen leaching method [25-27], freeze-drying method has 
become a common used method for preparing polymers-scaffolds especially for collagen and gelatin 
scaffolds [28]. Pre-prepared ice particulates can be mixed with naturally derived polymers before 
freeze-drying to precisely control pore structures of scaffolds [29, 30]. 
Based on the above considerations, functional composite porous scaffold of AuNRs and gelatin 
were fabricated by incorporating AuNRs in gelatin matrices through a freeze-drying method in this 
study. Ice particulates with optimized size were used as a template and mixed with AuNRs/gelatin 
mixture solution to construct the pore structures of scaffolds. The composite porous scaffolds of 
AuNRs and gelatin with well controlled pore structures were applied for 3D culture of human 
bone-marrow derived mesenchymal stem cells (hMSCs) to explore their capacity to promote 
adipogenic differentiation of hMSCs. 
4.3 Materials and methods 
4.3.1 Preparation and characterization of AuNRs-gelatin composite porous scaffolds 
AuNRs-gelatin composite porous scaffolds were prepared by freeze-drying the mixture solution 
of gelatin-coated AuNRs, gelatin and pre-prepared ice particulates as previously reported [29, 31]. 
Briefly, the ultrapure water were sprayed into liquid nitrogen to prepare the ice particles. Then the 
proper size (between 425 μm and 500 μm) of pre-prepared ice particles was optimized by sieving the 
ice particles with two meshes. Subsequently, A 70% acetic acid solution of 8 (w/v) % gelatin was 
mixed with 4.0 or 8.0 mM AuNRs solution at a ratio of 1:1 (v/v) under sonication to prepare 
AuNRs/gelatin mixture solutions. The final concentration of gelatin in the mixture solutions was 4 
(w/v) % while AuNRs concentration was 2.0 and 4.0 mM because our previous study showed that 
these two concentrations had good heating effect. The ice particulates, gelatin aqueous solution and 
AuNRs/gelatin mixture solution were kept in the chamber setting the temperature of -4 °C for 6 
hours to balance. Subsequently, 7.0 g ice particles were homogenously mixed with 3 mL 
AuNRs-gelatin mixture solution. The mixture of ice particulates and AuNRs-gelatin solution was 
poured into a silicone mold. Finally, the whole constructs were transferred into -20 °C freezer for 12 
hours and then moved to a -80 °C freezer for 4 hours. After that, the constructs were transferred into 
the freeze-dryer (FDU-2200, Japan) for freeze-drying to obtain the porous scaffolds. Then the 
AuNRs-gelatin porous composite scaffolds were chemically cross-linked using 
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide and N-hydroxysuccimide (EDC/NHS) to obtain the 
AuNRs-gelatin composite porous scaffolds. The morphology of AuNRs-gelatin composite scaffolds 
was characterized with a field emission scanning electron microscope (FESEM: SU8220, Hitachi, 
Japan). The AuNRs-gelatin composite scaffold prepared with an AuNRs concentration of 2.0 and 4.0 
mM was defined as 2.0 mM AuNRs-gelatin scaffold and 4.0 mM AuNRs-gelatin scaffold, 
respectively. Gelatin scaffold without incorporation of AuNRs was also prepared as a control with 
the above-mentioned procedures without addition of AuNRs. 
Pore size of gelatin scaffold and AuNRs-gelatin composite scaffolds was analyzed by measuring the 
diameters of pores from four SEM images of each type of scaffold with a ImageJ software. 
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4.3.2 In vitro culture of hMSCs 
The hMSCs at passage 2 (P2) were obtained from Lonza (Walkersville MD, USA) and subcultured in 
basal medium (Lonza, Swiss). When the cells proliferated to 80% in the flask, the medium was removed and 
washed with PBS. Then 0.25% trypsin solution was added into flask and incubated for 5 min to detach the 
cells from the surface of flask and stocked in liquid nitrogen. The harvested hMSCs (P4, 4.0×106 cells/mL ) 
suspension was seeded into both sides of gelatin scaffold, 2.0 mM AuNRs-gelatin scaffold and 4.0 mM 
AuNRs-gelatin scaffold and cultured in DMEM medium. Then the medium was refreshed every 3 days by 
adding the 1 μM dexamethasone, 0.5 mM Methyl-isobutylxanthine, 100 μM Indomethacin and 10 μg/mL 
insulin.  
4.3.3 Adhesion of hMSCs in AuNRs-gelatin composite scaffolds 
Cell attachment was analyzed by SEM observation. Briefly, after being cultured for 1 day, the 
hMSCs were fixed in the gelatin porous scaffold, 2.0 mM AuNRs-gelatin porous composite scaffold 
and 4.0 mM AuNRs-gelatin porous composite scaffold using 2.5% glutaraldehyde solution. 
Subsequently, the fixed samples were dehydrated by an gradient alcohol series including 50%, 70%, 
80%, 90%, 100%, 100% ethanol: H2O (w/w%). Then these samples were treated an gradient an 
t-Butyl alcohol series including 50%, 70%, 80%, 90%, 100%, 100% t-Butyl alcohol: ethanol (w/w%). 
Finally, these samples were immersed into 100% t-Butyl alcohol solution and kept at 4 oC for 
freezing. After that, these samples were lyophilized to observe cell adhesion and morphology in 
these three types of AuNRs-gelatin porous composite scaffolds by FE-SEM.. 
4.3.4 DNA quantification assay of hMSCs in AuNRs-gelatin composite scaffolds 
 Cell proliferation was investigated by measuring DNA amount of hMSCs cultured in gelatin porous 
scaffold, 2.0 mM AuNRs-gelatin porous composite scaffold and 4.0 mM AuNRs-gelatin porous composite 
scaffold. Briefly, after culture of hMSCs in AuNRs-gelatin porous composite scaffold for 1, 7 and 14 days, 
the hMSCs were fixed in AuNRs-gelatin porous composite scaffold using 4% paraformaldehyde 
solution. Then the samples were washed with ultrapure water, frozen in a -80 oC freezer and 
freeze-dried for 2 days. Subsequently, the freeze-dried samples were digested using the papain 
solution (400 μg/mL, pH: 6.0, phosphate buffer solvent). After that, the DNA dissolved in papain 
solution was mixed with Hoechst 33250 dye and detected using the fluorescence spectrometer. The 
mean and standard deviation were calculated through three parallel samples of each group. 
4.3.5 Oil Red O staining and quantitative analysis in AuNRs-gelatin composite scaffolds 
Oil Red O staining was carried out to observe lipid vacuoles formation. Briefly, after culture of hMSCs 
in gelatin porous scaffold, 2.0 mM AuNRs-gelatin porous composite scaffold and 4.0 mM AuNRs-gelatin 
porous composite scaffold for 14 days, the hMSCs were fixed in these three types of scaffolds using 4% 
paraformaldehyde solution. After that, the samples were washed with ultrapure water and immersed into 
isopropanol solution (60%) and then immersed into Oil Red O solution to stain the lipid vacuoles. 
Subsequently, the stained samples were imaged under the microscope. In addition, the Oil Red O dye stained 
in these three types of scaffolds was extracted by treatment with isopropanol for 2 hours at room temperature. 
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Finally, the absorbance value was measured with a microplate reader at a wavelength of 540 nm [32]. 
4.3.6 Real-time PCR assay for adipogenesis-related genes expression 
After culture of hMSCs in gelatin porous scaffold, 2.0 mM AuNRs-gelatin porous composite scaffold 
and 4.0 mM AuNRs-gelatin porous composite scaffold for 14 days, the expression level of 
adipogenesis-related genes containing fatty acid binding protein 4 (FABP4), peroxisome 
proliferator-activated receptor gamma (PPARG), CCAAT/enhancer binding protein (CEBPA) ipoprotein 
lipase (LPL) and fatty acid synthase (FASN) was detected using real-time polymerase chain reaction 
(RT-PCR). Briefly, the hMSCs/AuNRs-gelatin composite scaffolds were transferred into a niche containing 
liquid nitrogen to be frozen, then the samples were crushed into powders with a special crushing machine. 
Subsequently, the powders were transferred into Sepasol solution for isolating total RNA from samples. After 
that, the first stand cDNA synthesis kit was used to convert the extracted RNA into cDNA according to the 
protocol offered by applied biosystems. Finally, the RT-PCR was carried out to detected the expression level 
of the adipogensis-related genes using RT-PCR system (7500, applied biosystems, USA) [33]. The serial 
number of primer and prober for different adipogensis-related genes were listed in Table 4.1. Moreover, the 
endogenous control was the expression of GAPDH and the 2-△△Ct method was used to calculate the relative 
gene expression value. The hMSCs at P4 used for cell seeding was used as a control for comparison. Every 
three samples were used for the measurement to calculate the average and standard deviation. The mean and 
standard deviation were calculated through three parallel samples of each group. 
 
Table 4.1 The serial number of primer and probe for real-time PCR 
 
 
 
 
 
 
 
 
4.3.7  Statistical analysis 
The quantitative experiment in this study was repeated using three parallel samples and the results were 
expressed with average ± standard deviation (SD). The statistical analysis including significant difference 
was carried out by one-way ANOVA analysis software. The p value of 0.05 was considered statistically 
significant difference. The data were classified according to their p values and denoted by (*) for p less than 
0.05, (**) for p less than 0.01 and (***) for p less than 0.001 
mRNA Oligonucleotide 
GAPDH 
PPARG 
LPL 
FABP4 
FASN 
CEBPA 
Hs99999905_m1 
Hs01115510_m1 
Hs00173425_m1 
Hs00609791_m1 
Hs00188012_m1 
Hs00269972_s1 
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4.4  Results 
4.4.1 Morphology and pore structure of AuNRs-gelatin composite scaffolds  
SEM observation showed that the AuNRs-gelatin composite scaffolds had spherical large 
micropores with good interconnectivity, which were the same as those of the gelatin porous scaffold 
(Fig. 4.1). The size of the spherical large micropores (Table 4.2) in gelatin scaffold, 2.0 mM 
AuNRs-gelatin scaffold and 4.0 mM AuNRs-gelatin scaffold was 439 ± 38 μm, 442 ± 21 μm and 
435 ± 44 μm, respectively. The large micropore size was at the same range because the same ice 
particulates with a diameter range between 425 μm and 500 μm were optimized for preparation of 
the gelatin scaffold and 2.0 mM and 4.0 mM AuNRs-gelatin composite scaffolds. Small micropores 
connecting the large micropores were observed on the wall of the spherical large micropores. The 
size of interconnected small micropores (Table 4.2) in gelatin scaffold, 2.0 mM AuNRs-gelatin 
scaffold and 4.0 mM AuNRs-gelatin scaffold was 66 ± 25 μm, 76 ± 18 μm and 69 ± 23 μm, 
respectively. The three types of scaffolds had the same range of small micropores. 
 
Fig. 4.1 SEM images of gelatin scaffold (S1), 2.0 mM AuNRs-gelatin scaffold (S2) and 4.0 mM 
AuNRs-gelatin scaffold (S3). 
  
 
Table 4.2 Pore size analysis of gelatin scaffold (S1), 2.0 mM AuNRs-gelatin scaffold (S2) and 4.0 mM 
AuNRs-gelatin scaffold (S3). 
 
 
4.4.2 Adhesion and distribution of hMSCs in AuNRs-gelatin composite scaffolds 
To investigate the capacity of AuNRs-gelatin composite scaffolds for adipose tissue regeneration, the 
composite scaffolds were used for 3D culture of hMSCs. After 1 day culture, attachment and distribution of 
hMSCs within the scaffolds were observed using SEM (Fig. 4.2). SEM images showed that hMSCs adhered 
well with typical filopodia on the wall of micropores in all the gelatin scaffold and AuNRs-gelatin composite 
           Sample 
 
Pore size (μm) 
S1 S2 S3 
Spherical  
large micropores 
439 ± 38 442 ± 21 435 ± 44 
Interconnected 
Small micropores  
66 ± 25 76 ± 18 69 ± 23 
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scaffolds. The cells distributed throughout the scaffolds. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.2 SEM images of hMSCs/scaffold constructs at a low magnification (a-c) and a high magnification 
(d-f) after hMSCs were cultured in gelatin scaffold (S1, a, d), 2.0 mM AuNRs-gelatin scaffold (S2, b, e) and 
4.0 mM AuNRs-gelatin scaffold (S3, c, f) for 1 day. 
4.4.3 Proliferation of hMSCs in AuNRs-gelatin composite scaffolds 
 DNA quantification (Fig. 4.3) showed that DNA content increased significantly after being cultured for 
1, 7 and 14 days in all the scaffolds. DNA content had no significant difference among all these three kinds 
of scaffolds. The results suggested that both gelatin scaffold and 2.0 mM, 4.0 mM AuNRs-gelatin composite 
scaffolds supported cell adhesion and promoted proliferation of hMSCs. Incorporation of AuNRs into gelatin 
scaffold had no significant influence on adhesion and proliferation of hMSCs. 
Fig. 4.3 Quantification of DNA content of hMSCs/scaffold constructs after hMSCs were cultured in gelatin 
scaffold (S1), 2.0 mM AuNRs-gelatin scaffold (S2) and 4.0 mM AuNRs-gelatin scaffold (S3) for 1, 7 and 14 
days. The data are presented as mean ± standard deviation, n = 3. Significant difference: *** p < 0.001. 
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4.4.4 Lipid vacuoles formation in AuNRs-gelatin composite scaffolds 
Adipogenic differentiation of hMSCs in AuNRs-gelatin composite scaffolds was analyzed by Oil Red O 
staining and expression of adipogenesis genes after being cultured in adipogenesis-induction medium for 14 
days. Oil Red O staining images showed that lipid vacuoles were detected when hMSCs were cultured in 
gelatin scaffold, 2.0 mM AuNRs-gelatin scaffold and 4.0 mM AuNRs-gelatin scaffold (Fig. 4.4a-c). 
Quantification of the extracted Oil Red O dye showed that lipid vacuoles amount had no significant 
difference among the three types of scaffolds (Fig. 4.4d). 
 
Fig. 4.4 Oil Red O staining images (a-c) and quantification of extracted Oil Red O dye (d) of cell/scaffold 
constructs after hMSCs were cultured in gelation scaffold (S1, a), 2.0 mM AuNRs-gelatin scaffold (S2, b) 
and 4.0 mM AuNRs-gelatin scaffold (S3, c) for 14 days. The data are presented as average ± standard 
deviation, n = 3. No significant difference: N.S. 
4.4.5 Expression of adipogenesis-related genes in AuNRs-gelatin composite scaffolds 
Expression of genes encoding CEBPA, PPARG, LPL, FABP4 and FASN showed that all these genes 
were upregulated when hMSCs were cultured in gelatin scaffold and AuNRs-gelatin composite scaffolds in 
comparison with the subcultured hMSCs (control) (Fig. 4.5). Expression level of these genes had no 
significant difference among gelatin scaffold, 2.0 mM AuNRs-gelatin scaffold and 4.0 mM AuNRs-gelatin 
scaffold. Oil Red O staining and gene expression results indicated that gelatin scaffold and AuNRs-gelatin 
composite scaffolds had the same promotive effects on adipogenic differentiation of hMSCs. Incorporation 
of AuNRs in gelatin scaffold had no influence on the promotive effect of gelatin scaffold for adipogenic 
differentiation of hMSCs. 
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Fig. 4.5 Expression of genes encoding CEBPA (a), PPARG (b), LPL (c), FABP4 (d) and FASN (e) by 
hMSCs cultured in gelatin scaffold (S1), 2.0 mM AuNRs-gelatin scaffold (S2) and 4.0 mM AuNRs-gelatin 
scaffold (S3) for 14 days. The subcultured hMSCs used for cell seeding was used as a control. Data represent 
means ± SD, n = 3. No significant difference: N.S.; significant difference: *** p < 0.001.  
4.5 Discussion 
Successful reconstruction of tumor-initiated breast defects after surgical resection remain a 
critical challenge in breast cancer therapy [6, 34-36]. To address this issue, bifunctional 
AuNRs-gelatin composite porous scaffolds were designed and prepared by incorporating 
photothermal conversion nanoparticles, AuNRs, in gelatin porous scaffold. AuNRs aqueous 
solutions at a different concentration of AuNRs (2.0, 4.0 mM) were used to introduce different 
amount of AuNRs in the composite scaffolds. Optimized ice particulates were used as a template to 
construct the pore structure of composite scaffolds. The composite scaffolds had the same size of 
spherical large micropores and small micropores as those of gelatin scaffold (Fig. 4.1 and Table 4.2). 
The spherical large micropores were well interconnected by the small micropores on the walls of 
spherical large micropores. All the gelatin scaffold and composite scaffolds had the same pore 
structures because the same ice particulates were used and the freezing temperature was the same 
during the preparation process. The size and shape of spherical large micropores were controlled by 
the incorporated ice particulates based on the ground that they should be the negative replicas of 
pre-prepared ice particulates. While the small micropores on the wall of large micropores should be 
the replica of new ice crystals that were formed around the pre-prepared ice particulates during 
freezing process of the ice particulates-AuNRs-gelatin mixture solution. Porous structure and good 
interconnectivity of the composite scaffolds were beneficial to the cell adhesion and distribution 
throughout the scaffolds as shown in Fig. 4.2. 
Adipose tissue regeneration is required to realize breast reconstruction to improve quality of life 
of the patients. The potential of AuNRs-gelatin composite scaffolds for adipose tissue engineering 
was confirmed by examining their promotive effect on adipogenic differentiation of hMSCs. The 
composite scaffolds not only supported adhesion and proliferation of hMSCs as shown in Fig. 4.2 
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and Fig. 4.3, but also enhanced formation of lipid vacuoles (Fig. 4.4) and expression of adipogenic 
genes (CEBPA, PPARG, LPL, FABP4 and FASN) (Fig. 4.5). In addition, the composite scaffolds 
showed the same level of lipid vacuole formation and the same adipogensis-related gene expression 
level as did the gelatin scaffold, which suggested incorporation of AuNRs had no influence on 
adipogenic differentiation of hMSCs. Although in vivo adipogenesis promotion effect of the 
composite scaffolds will be further confirmed in future, the results in present study indicated the 
AuNRs-gelatin composite scaffolds had a bifunctional property for simultaneous photothermal 
ablation of breast tumor and adipogenic differentiation of hMSCs. 
4.6 Conclusions 
In summary, functional AuNRs-gelatin porous scaffolds were prepared by introducing AuNRs in the 
porous structure of gelatin matrices via a freeze-drying method. Pre-prepared ice particulates were used as 
templates to construct the pore structure of scaffolds. The AuNRs-gelatin composite scaffolds showed well 
controlled pore structure with interconnectivity. The AuNRs-gelatin composite scaffolds supported adhesion, 
promoted proliferation and enhanced adipogenic differentiation of hMSCs. The results demonstrated that the 
AuNRs-gelatin scaffolds had the potential of adipose tissue regeneration for breast reconstruction after breast 
cancer therapy.  
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Concluding remarks and future prospects 
 
 
 
 
5.1 Concluding remarks 
This dissertation describes the design and preparation of bifunctional AuNRs-gelatin composite 
scaffolds for both photothermal therapy of breast tumor and adipose tissue regeneration. 
 
In chapter 1, general backgrounds are introduced to describe the current challenges and problems for 
breast cancer therapy, especially for the new strategy: photothermal therapy. In order to achieve the high 
repeated photothermal efficiency and realize the new adipose tissue regeneration for breast reconstruction, 
bifunctional scaffolds are designed by incorporating photothermal conversion nanoparticles into a porous 
scaffold, which provide photothermal ablation of breast tumor and induce adipogenic differentiation of 
MSCs for adipose tissue regeneration.   
 
In chapter 2, gold nanorods (AuNRs) were synthesized by a seed-mediated growth method, and BSA 
were coated on the surface of AuNRs. The BSA-coated AuNRs showed good monodispersity and low 
cytotoxicity as well as high cellular uptake by tumor cells in the studied concentration. The BSA-coated 
AuNRs also showed excellent photothermal performance based on the strong SPR in the NIR region and 
showed high photothermal ablating efficiency towards breast tumor cells. Moreover, the photothermally 
ablated tumor cells triggered immune-stimulatory responses of immature DCs through both cell–cell 
interaction and soluble factors released from the ablated tumor cells. 
 
In chapter 3, AuNRs-gelatin porous scaffolds were prepared by introducing AuNRs in porous gelatin 
matrices via a freeze-drying method. Pre-prepared ice particulates were used as a template to control the pore 
structure. The AuNRs-gelatin composite scaffolds showed high photothermal conversion efficiency. The 
AuNRs-gelatin composite scaffolds also showed excellent photothermal ablation capacity of breast tumor 
cells in vitro and in vivo. Moreover, DCs were activated by ablated tumor cells in AuNRs-gelatin composite 
scaffold. 
 
In chapter 4, functional AuNRs-gelatin porous scaffolds were also used for adipose tissue regeneration. 
The AuNRs-gelatin composite scaffolds supported adhesion, promoted proliferation, and enhanced the 
adipogenic differentiation of hMSCs. The results demonstrated that the AuNRs-gelatin scaffolds had 
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simultaneous effects on photothermal ablation of breast tumor and regeneration of adipose tissue. The 
composite scaffolds should be useful for the treatment of breast tumors.  
In conclusions, a bifunctional scaffold of gelatin and AuNRs with well-controlled pore structures were 
designed and used for both photothermal ablation of tumor cells and adipogenic differentiation of hMSCs, 
indicating that the AuNRs-gelatin composite scaffolds had a potential for adipose tissue regeneration for 
breast reconstruction after breast tumor therapy.  
 
5.2 Future prospects  
The achievements and conclusions of this study provide useful information for the design and 
application of multifunctional biomaterials for both photothermal-immunotherapy of primary and metastatic 
cancer and tissue regeneration of tumor-initiated detects. In order to further demonstrate the multifunctions 
of AuNRs-gelatin composite scaffolds and their future applications in the clinic, the following studies should 
be considered in the future. 
(1) Based on the current problems of nanoparticles-mediated photothermal therapy, the immune responses of 
DCs triggered by photothotermally ablated tumor cells using BSA-coated AuNRs were demonstrated in vitro. 
Immunotherapy of metastatic cancer induced by ablated tumor cells using photothermal effects of 
BSA-coated AuNRs in vivo is required. 
(2) AuNRs-gelatin composite scaffolds showed excellent photothermal ablation effects towards breast tumor 
cells in vitro and in vivo. The photothermal-immunotherapy of AuNRs-gelatin composite scaffolds for 
primary and metastatic cancer should be investigated by animal experiments. 
(3) Besides breast tumor therapy, the adipogenic differentiation of hMSCs in AuNRs-gelatin composite 
porous scaffolds was successfully induced in vitro. For clinic application of the porous scaffolds for effective 
breast reconstruction, in vivo adipogenesis promotion effect of the composite scaffolds after photothermal 
therapy of breast tumor should be considered. 
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